advertisement

List of abstracts related to

Listed by Classification

11.1 General management, indication (809 abstracts found)

94971 The glaucoma intensive treatment study: interim results from an ongoing longitudinal randomized clinical trial
Bengtsson B
Acta Ophthalmologica 2022; 100: e455-e462 (IGR: 22-2)

94530 Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS)
King AJ
British Medical Journal (Clinical Research Edition) 2021; 373: n1014 (IGR: 22-2)

94503 Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana
Ofei-Palm CNK; Tagoe NN
ClinicoEconomics and outcomes research : CEOR 2021; 13: 619-627 (IGR: 22-2)

94530 Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS)
Hudson J
British Medical Journal (Clinical Research Edition) 2021; 373: n1014 (IGR: 22-2)

94971 The glaucoma intensive treatment study: interim results from an ongoing longitudinal randomized clinical trial
Lindén C
Acta Ophthalmologica 2022; 100: e455-e462 (IGR: 22-2)

94503 Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana
Jatoe D
ClinicoEconomics and outcomes research : CEOR 2021; 13: 619-627 (IGR: 22-2)

94530 Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS)
Fernie G
British Medical Journal (Clinical Research Edition) 2021; 373: n1014 (IGR: 22-2)

94971 The glaucoma intensive treatment study: interim results from an ongoing longitudinal randomized clinical trial
Heijl A; Andersson-Geimer S; Andersson-Geimer S
Acta Ophthalmologica 2022; 100: e455-e462 (IGR: 22-2)

94503 Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana
Agyare A
ClinicoEconomics and outcomes research : CEOR 2021; 13: 619-627 (IGR: 22-2)

94530 Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS)
Kernohan A
British Medical Journal (Clinical Research Edition) 2021; 373: n1014 (IGR: 22-2)

94971 The glaucoma intensive treatment study: interim results from an ongoing longitudinal randomized clinical trial
Aspberg J
Acta Ophthalmologica 2022; 100: e455-e462 (IGR: 22-2)

94530 Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS)
Azuara-Blanco A
British Medical Journal (Clinical Research Edition) 2021; 373: n1014 (IGR: 22-2)

94971 The glaucoma intensive treatment study: interim results from an ongoing longitudinal randomized clinical trial
Aspberg J
Acta Ophthalmologica 2022; 100: e455-e462 (IGR: 22-2)

94503 Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana
Ankrah D
ClinicoEconomics and outcomes research : CEOR 2021; 13: 619-627 (IGR: 22-2)

94971 The glaucoma intensive treatment study: interim results from an ongoing longitudinal randomized clinical trial
Aspberg J; Jóhannesson G
Acta Ophthalmologica 2022; 100: e455-e462 (IGR: 22-2)

94530 Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS)
Burr J; Homer T; Shabaninejad H; Sparrow JM; Garway-Heath D; Barton K; Norrie J; McDonald A; Vale L; Maclennan G;
British Medical Journal (Clinical Research Edition) 2021; 373: n1014 (IGR: 22-2)

92438 What Is New in Glaucoma: From Treatment to Biological Perspectives
Nuzzi R
Journal of Ophthalmology 2021; 2021: 5013529 (IGR: 22-1)

92362 What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews
Qureshi R
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)

92168 New considerations for the clinical efficacy of old and new topical glaucoma medications
MacIver S
Clinical and Experimental Optometry 2021; 104: 350-366 (IGR: 22-1)

92609 The future is old - Patients with topical ocular hypotensive treatment in the Nordic region between 2008 and 2017 with projections for 2040
Bro T
Acta Ophthalmologica 2021; 99: e1442-e1448 (IGR: 22-1)

91911 Advances in medical therapy for glaucoma
Ostler E
Current Opinions in Ophthalmology 2021; 32: 129-133 (IGR: 22-1)

92479 Optical Coherence Tomography Angiography Vessel Density Changes in Normal-tension Glaucoma Treated with Carteolol, Brimonidine, or Dorzolamide
Lin YH
Journal of Glaucoma 2021; 30: 690-696 (IGR: 22-1)

91905 Glaucoma
Kang JM; Tanna AP
The Medical clinics of North America 2021; 105: 493-510 (IGR: 22-1)

92479 Optical Coherence Tomography Angiography Vessel Density Changes in Normal-tension Glaucoma Treated with Carteolol, Brimonidine, or Dorzolamide
Su WW
Journal of Glaucoma 2021; 30: 690-696 (IGR: 22-1)

92609 The future is old - Patients with topical ocular hypotensive treatment in the Nordic region between 2008 and 2017 with projections for 2040
Wickström K
Acta Ophthalmologica 2021; 99: e1442-e1448 (IGR: 22-1)

91911 Advances in medical therapy for glaucoma
Rhee D
Current Opinions in Ophthalmology 2021; 32: 129-133 (IGR: 22-1)

92168 New considerations for the clinical efficacy of old and new topical glaucoma medications
Stout N
Clinical and Experimental Optometry 2021; 104: 350-366 (IGR: 22-1)

92438 What Is New in Glaucoma: From Treatment to Biological Perspectives
Marolo P
Journal of Ophthalmology 2021; 2021: 5013529 (IGR: 22-1)

92362 What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews
Azuara-Blanco A
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)

92168 New considerations for the clinical efficacy of old and new topical glaucoma medications
Ricci O
Clinical and Experimental Optometry 2021; 104: 350-366 (IGR: 22-1)

92362 What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews
Michelessi M
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)

92479 Optical Coherence Tomography Angiography Vessel Density Changes in Normal-tension Glaucoma Treated with Carteolol, Brimonidine, or Dorzolamide
Huang SM
Journal of Glaucoma 2021; 30: 690-696 (IGR: 22-1)

92438 What Is New in Glaucoma: From Treatment to Biological Perspectives
Nuzzi A
Journal of Ophthalmology 2021; 2021: 5013529 (IGR: 22-1)

92609 The future is old - Patients with topical ocular hypotensive treatment in the Nordic region between 2008 and 2017 with projections for 2040
Lindén C
Acta Ophthalmologica 2021; 99: e1442-e1448 (IGR: 22-1)

91911 Advances in medical therapy for glaucoma
Burney E
Current Opinions in Ophthalmology 2021; 32: 129-133 (IGR: 22-1)

92479 Optical Coherence Tomography Angiography Vessel Density Changes in Normal-tension Glaucoma Treated with Carteolol, Brimonidine, or Dorzolamide
Chuang LH
Journal of Glaucoma 2021; 30: 690-696 (IGR: 22-1)

91911 Advances in medical therapy for glaucoma
Sozeri Y
Current Opinions in Ophthalmology 2021; 32: 129-133 (IGR: 22-1)

92362 What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews
Virgili G
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)

92479 Optical Coherence Tomography Angiography Vessel Density Changes in Normal-tension Glaucoma Treated with Carteolol, Brimonidine, or Dorzolamide
Chen LC
Journal of Glaucoma 2021; 30: 690-696 (IGR: 22-1)

92362 What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews
Barbosa Breda J; Cutolo CA; Pazos M; Katsanos A; Garhöfer G; Kolko M; Prokosch-Willing V; Al Rajhi AA; Lum F; Musch D; Gedde S; Li T
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)

91388 Predictors of Initial Glaucoma Therapy with Laser Trabeculoplasty versus Medication: A Population-Based Study
Quinn MP; Quinn MP
Ophthalmology. Glaucoma 2021; 4: 358-364 (IGR: 21-4)

91095 Current Status of the Pharmacological Treatment of Glaucoma and Its Prospects
Shimazawa M
Yakugaku Zasshi 2021; 141: 61-66 (IGR: 21-4)

91646 Increased incidence of glaucoma medication usage in middle-aged Australian males taking antiretroviral medication - a population-based study
Lee WS
Journal of Ophthalmic Inflammation and Infection 2020; 10: 30 (IGR: 21-4)

90998 Achieving low target intraocular pressures in severe glaucoma
Warjri GB
European Journal of Ophthalmology 2020; 0: 1120672120979903 (IGR: 21-4)

91095 Current Status of the Pharmacological Treatment of Glaucoma and Its Prospects
Hara H
Yakugaku Zasshi 2021; 141: 61-66 (IGR: 21-4)

91646 Increased incidence of glaucoma medication usage in middle-aged Australian males taking antiretroviral medication - a population-based study
Parsons S
Journal of Ophthalmic Inflammation and Infection 2020; 10: 30 (IGR: 21-4)

91388 Predictors of Initial Glaucoma Therapy with Laser Trabeculoplasty versus Medication: A Population-Based Study
Johnson D
Ophthalmology. Glaucoma 2021; 4: 358-364 (IGR: 21-4)

90998 Achieving low target intraocular pressures in severe glaucoma
Sidhu T; Kishan A
European Journal of Ophthalmology 2020; 0: 1120672120979903 (IGR: 21-4)

91388 Predictors of Initial Glaucoma Therapy with Laser Trabeculoplasty versus Medication: A Population-Based Study
Whitehead M
Ophthalmology. Glaucoma 2021; 4: 358-364 (IGR: 21-4)

91646 Increased incidence of glaucoma medication usage in middle-aged Australian males taking antiretroviral medication - a population-based study
Cugley D
Journal of Ophthalmic Inflammation and Infection 2020; 10: 30 (IGR: 21-4)

90998 Achieving low target intraocular pressures in severe glaucoma
Behera AK
European Journal of Ophthalmology 2020; 0: 1120672120979903 (IGR: 21-4)

91388 Predictors of Initial Glaucoma Therapy with Laser Trabeculoplasty versus Medication: A Population-Based Study
Gill SS
Ophthalmology. Glaucoma 2021; 4: 358-364 (IGR: 21-4)

91646 Increased incidence of glaucoma medication usage in middle-aged Australian males taking antiretroviral medication - a population-based study
Rogers S
Journal of Ophthalmic Inflammation and Infection 2020; 10: 30 (IGR: 21-4)

90998 Achieving low target intraocular pressures in severe glaucoma
Shakrawal J
European Journal of Ophthalmology 2020; 0: 1120672120979903 (IGR: 21-4)

91388 Predictors of Initial Glaucoma Therapy with Laser Trabeculoplasty versus Medication: A Population-Based Study
Campbell RJ
Ophthalmology. Glaucoma 2021; 4: 358-364 (IGR: 21-4)

91646 Increased incidence of glaucoma medication usage in middle-aged Australian males taking antiretroviral medication - a population-based study
Lim LL
Journal of Ophthalmic Inflammation and Infection 2020; 10: 30 (IGR: 21-4)

90998 Achieving low target intraocular pressures in severe glaucoma
Selvan H
European Journal of Ophthalmology 2020; 0: 1120672120979903 (IGR: 21-4)

91646 Increased incidence of glaucoma medication usage in middle-aged Australian males taking antiretroviral medication - a population-based study
Hall A
Journal of Ophthalmic Inflammation and Infection 2020; 10: 30 (IGR: 21-4)

90998 Achieving low target intraocular pressures in severe glaucoma
Dada T; Pandey V; Sihota R
European Journal of Ophthalmology 2020; 0: 1120672120979903 (IGR: 21-4)

89937 Balancing treatments for patients with systemic hypertension and glaucoma
Shukla AG
Expert Opinion in Pharmacotherapy 2020; 21: 2225-2230 (IGR: 21-3)

89941 Current and new pharmacotherapeutic approaches for glaucoma
Shalaby WS
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040 (IGR: 21-3)

90372 Medical management of pediatric glaucoma: lessons learned from randomized clinical trials
Sacchi M
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 1579-1586 (IGR: 21-3)

90160 Do We Conform with European Glaucoma Society Guidelines in the Medical Treatment of Primary Open-Angle Glaucoma/Ocular Hypertension? Data from a Real-Life Practice
Alagöz N
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 747-753 (IGR: 21-3)

90470 Characteristics and Treatment Patterns of Newly Diagnosed Open-Angle Glaucoma Patients in the United States: An Administrative Database Analysis
Schwartz GF
Ophthalmology. Glaucoma 2021; 4: 117-125 (IGR: 21-3)

90617 Selective laser trabeculoplasty vs. topical medications for step-up treatment in primary open angle glaucoma: comparing clinical effectiveness, quality of life and cost-effectiveness
Yong MH
Medical Journal of Malaysia 2020; 75: 342-348 (IGR: 21-3)

90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Lin FB
Trials 2020; 21: 813 (IGR: 21-3)

89941 Current and new pharmacotherapeutic approaches for glaucoma
Shalaby WS
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040 (IGR: 21-3)

89938 Medical Management of Glaucoma
Emrani E
Klinische Monatsblätter für Augenheilkunde 2020; 237: 1241-1258 (IGR: 21-3)

90198 Treatment of glaucoma among elderly patients in Sofia
Marinova ME
Romanian journal of ophthalmology 2020; 64: 404-409 (IGR: 21-3)

90087 Current Medical Therapy and Future Trends in the Management of Glaucoma Treatment
Cvenkel B
Journal of Ophthalmology 2020; 2020: 6138132 (IGR: 21-3)

89937 Balancing treatments for patients with systemic hypertension and glaucoma
Shukla AG
Expert Opinion in Pharmacotherapy 2020; 21: 2225-2230 (IGR: 21-3)

89941 Current and new pharmacotherapeutic approaches for glaucoma
Shalaby WS
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040 (IGR: 21-3)

90372 Medical management of pediatric glaucoma: lessons learned from randomized clinical trials
Lizzio RAU
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 1579-1586 (IGR: 21-3)

90160 Do We Conform with European Glaucoma Society Guidelines in the Medical Treatment of Primary Open-Angle Glaucoma/Ocular Hypertension? Data from a Real-Life Practice
Tellioglu A
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 747-753 (IGR: 21-3)

90198 Treatment of glaucoma among elderly patients in Sofia
Naseva KE
Romanian journal of ophthalmology 2020; 64: 404-409 (IGR: 21-3)

90087 Current Medical Therapy and Future Trends in the Management of Glaucoma Treatment
Kolko M
Journal of Ophthalmology 2020; 2020: 6138132 (IGR: 21-3)

89937 Balancing treatments for patients with systemic hypertension and glaucoma
Razeghinejad R
Expert Opinion in Pharmacotherapy 2020; 21: 2225-2230 (IGR: 21-3)

90617 Selective laser trabeculoplasty vs. topical medications for step-up treatment in primary open angle glaucoma: comparing clinical effectiveness, quality of life and cost-effectiveness
Che Hamzah J
Medical Journal of Malaysia 2020; 75: 342-348 (IGR: 21-3)

90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Da Chen S
Trials 2020; 21: 813 (IGR: 21-3)

89941 Current and new pharmacotherapeutic approaches for glaucoma
Shankar V
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040 (IGR: 21-3)

90470 Characteristics and Treatment Patterns of Newly Diagnosed Open-Angle Glaucoma Patients in the United States: An Administrative Database Analysis
Patel A
Ophthalmology. Glaucoma 2021; 4: 117-125 (IGR: 21-3)

90198 Treatment of glaucoma among elderly patients in Sofia
Zdravkov TY
Romanian journal of ophthalmology 2020; 64: 404-409 (IGR: 21-3)

90470 Characteristics and Treatment Patterns of Newly Diagnosed Open-Angle Glaucoma Patients in the United States: An Administrative Database Analysis
Naik R
Ophthalmology. Glaucoma 2021; 4: 117-125 (IGR: 21-3)

90160 Do We Conform with European Glaucoma Society Guidelines in the Medical Treatment of Primary Open-Angle Glaucoma/Ocular Hypertension? Data from a Real-Life Practice
Bektasoglu DL
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 747-753 (IGR: 21-3)

89937 Balancing treatments for patients with systemic hypertension and glaucoma
Myers JS
Expert Opinion in Pharmacotherapy 2020; 21: 2225-2230 (IGR: 21-3)

90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Song YH
Trials 2020; 21: 813 (IGR: 21-3)

90372 Medical management of pediatric glaucoma: lessons learned from randomized clinical trials
Villani E
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 1579-1586 (IGR: 21-3)

89941 Current and new pharmacotherapeutic approaches for glaucoma
Razeghinejad R
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040 (IGR: 21-3)

90160 Do We Conform with European Glaucoma Society Guidelines in the Medical Treatment of Primary Open-Angle Glaucoma/Ocular Hypertension? Data from a Real-Life Practice
Yasar T
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 747-753 (IGR: 21-3)

90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Wang W
Trials 2020; 21: 813 (IGR: 21-3)

89941 Current and new pharmacotherapeutic approaches for glaucoma
Katz LJ
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040 (IGR: 21-3)

90470 Characteristics and Treatment Patterns of Newly Diagnosed Open-Angle Glaucoma Patients in the United States: An Administrative Database Analysis
Lunacsek O
Ophthalmology. Glaucoma 2021; 4: 117-125 (IGR: 21-3)

90372 Medical management of pediatric glaucoma: lessons learned from randomized clinical trials
Monsellato G
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 1579-1586 (IGR: 21-3)

90198 Treatment of glaucoma among elderly patients in Sofia
Dabov SD
Romanian journal of ophthalmology 2020; 64: 404-409 (IGR: 21-3)

90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Jin L
Trials 2020; 21: 813 (IGR: 21-3)

90160 Do We Conform with European Glaucoma Society Guidelines in the Medical Treatment of Primary Open-Angle Glaucoma/Ocular Hypertension? Data from a Real-Life Practice
Basgil Pasaoglu I
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 747-753 (IGR: 21-3)

90372 Medical management of pediatric glaucoma: lessons learned from randomized clinical trials
Lucentini S
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 1579-1586 (IGR: 21-3)

90470 Characteristics and Treatment Patterns of Newly Diagnosed Open-Angle Glaucoma Patients in the United States: An Administrative Database Analysis
Ogbonnaya A
Ophthalmology. Glaucoma 2021; 4: 117-125 (IGR: 21-3)

90372 Medical management of pediatric glaucoma: lessons learned from randomized clinical trials
Cremonesi E
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 1579-1586 (IGR: 21-3)

90470 Characteristics and Treatment Patterns of Newly Diagnosed Open-Angle Glaucoma Patients in the United States: An Administrative Database Analysis
Campbell J
Ophthalmology. Glaucoma 2021; 4: 117-125 (IGR: 21-3)

90160 Do We Conform with European Glaucoma Society Guidelines in the Medical Treatment of Primary Open-Angle Glaucoma/Ocular Hypertension? Data from a Real-Life Practice
Altan AC
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 747-753 (IGR: 21-3)

90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Liu BQ; Liu YH
Trials 2020; 21: 813 (IGR: 21-3)

90372 Medical management of pediatric glaucoma: lessons learned from randomized clinical trials
Luccarelli S
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 1579-1586 (IGR: 21-3)

90160 Do We Conform with European Glaucoma Society Guidelines in the Medical Treatment of Primary Open-Angle Glaucoma/Ocular Hypertension? Data from a Real-Life Practice
Solmaz B
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 747-753 (IGR: 21-3)

90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Chen ML
Trials 2020; 21: 813 (IGR: 21-3)

90160 Do We Conform with European Glaucoma Society Guidelines in the Medical Treatment of Primary Open-Angle Glaucoma/Ocular Hypertension? Data from a Real-Life Practice
Basarır B
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 747-753 (IGR: 21-3)

90372 Medical management of pediatric glaucoma: lessons learned from randomized clinical trials
Serafino M; Nucci P
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 1579-1586 (IGR: 21-3)

90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Gao K; Friedman DS; Jonas JB; Aung T; Lv L; Liu YZ; Zhang XL;
Trials 2020; 21: 813 (IGR: 21-3)

86671 Intraocular pressure changes following topical ocular hypotensive medications washout
Ho H
British Journal of Ophthalmology 2021; 105: 205-209 (IGR: 21-2)

86701 Intraocular Pressure Following Prerandomization Glaucoma Medication Washout in the HORIZON and COMPASS Trials
Johnson TV
American Journal of Ophthalmology 2020; 216: 110-120 (IGR: 21-2)

86671 Intraocular pressure changes following topical ocular hypotensive medications washout
Daas A
British Journal of Ophthalmology 2021; 105: 205-209 (IGR: 21-2)

86701 Intraocular Pressure Following Prerandomization Glaucoma Medication Washout in the HORIZON and COMPASS Trials
Jampel HD
American Journal of Ophthalmology 2020; 216: 110-120 (IGR: 21-2)

86671 Intraocular pressure changes following topical ocular hypotensive medications washout
Ho J; Alaghband P; Galvis EA; de Antonio Ramirez A; Grassi P; Lim R; Lim KS
British Journal of Ophthalmology 2021; 105: 205-209 (IGR: 21-2)

84728 Nanotechnology for Medical and Surgical Glaucoma Therapy-A Review
Occhiutto ML
Advances in Therapy 2020; 37: 155-199 (IGR: 21-1)

84463 Treatment choices for newly diagnosed primary open angle and ocular hypertension patients
Garg A
Eye 2020; 34: 60-71 (IGR: 21-1)

84465 10-year trends in English primary care glaucoma prescribing
Hogg HDJ
Eye 2020; 34: 192-196 (IGR: 21-1)

84667 Systematic reviews and randomised controlled trials on open angle glaucoma
Wormald R
Eye 2020; 34: 161-167 (IGR: 21-1)

84831 Comparing glaucoma medications and general demographics in a sample of glaucoma patients treated in private practice with nationwide registry data in Finland
Parkkari M
Acta Ophthalmologica 2019; 0: (IGR: 21-1)

84920 Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017
Yu L
PLoS ONE 2020; 15: e0227595 (IGR: 21-1)

85065 Baseline characteristics of participants in the Treatment of Advanced Glaucoma Study (TAGS): A multicentre randomised controlled trial
King AJ
American Journal of Ophthalmology 2020; 213: 186-194 (IGR: 21-1)

84615 Secondary Neuroprotection in Glaucoma by Reduction of Intraocular Pressure
Unterlauft JD
Klinische Monatsblätter für Augenheilkunde 2020; 237: 150-157 (IGR: 21-1)

84667 Systematic reviews and randomised controlled trials on open angle glaucoma
Virgili G
Eye 2020; 34: 161-167 (IGR: 21-1)

84831 Comparing glaucoma medications and general demographics in a sample of glaucoma patients treated in private practice with nationwide registry data in Finland
Taipale J
Acta Ophthalmologica 2019; 0: (IGR: 21-1)

84728 Nanotechnology for Medical and Surgical Glaucoma Therapy-A Review
Maranhão RC
Advances in Therapy 2020; 37: 155-199 (IGR: 21-1)

85065 Baseline characteristics of participants in the Treatment of Advanced Glaucoma Study (TAGS): A multicentre randomised controlled trial
Hudson J
American Journal of Ophthalmology 2020; 213: 186-194 (IGR: 21-1)

84465 10-year trends in English primary care glaucoma prescribing
Connor A
Eye 2020; 34: 192-196 (IGR: 21-1)

84463 Treatment choices for newly diagnosed primary open angle and ocular hypertension patients
Gazzard G
Eye 2020; 34: 60-71 (IGR: 21-1)

84920 Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017
Ding K; Luo L
PLoS ONE 2020; 15: e0227595 (IGR: 21-1)

84728 Nanotechnology for Medical and Surgical Glaucoma Therapy-A Review
Costa VP
Advances in Therapy 2020; 37: 155-199 (IGR: 21-1)

85065 Baseline characteristics of participants in the Treatment of Advanced Glaucoma Study (TAGS): A multicentre randomised controlled trial
Fernie G
American Journal of Ophthalmology 2020; 213: 186-194 (IGR: 21-1)

84667 Systematic reviews and randomised controlled trials on open angle glaucoma
Azuara-Blanco A
Eye 2020; 34: 161-167 (IGR: 21-1)

84831 Comparing glaucoma medications and general demographics in a sample of glaucoma patients treated in private practice with nationwide registry data in Finland
Uusitalo H
Acta Ophthalmologica 2019; 0: (IGR: 21-1)

84920 Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017
Yu Z
PLoS ONE 2020; 15: e0227595 (IGR: 21-1)

85065 Baseline characteristics of participants in the Treatment of Advanced Glaucoma Study (TAGS): A multicentre randomised controlled trial
Burr J
American Journal of Ophthalmology 2020; 213: 186-194 (IGR: 21-1)

84728 Nanotechnology for Medical and Surgical Glaucoma Therapy-A Review
Konstas AG
Advances in Therapy 2020; 37: 155-199 (IGR: 21-1)

85065 Baseline characteristics of participants in the Treatment of Advanced Glaucoma Study (TAGS): A multicentre randomised controlled trial
Azuara-Blanco A; Sparrow J; Barton K; Garway-Heath DF; Kernohan A; Maclennan G;
American Journal of Ophthalmology 2020; 213: 186-194 (IGR: 21-1)

82588 ISOPT Hot Topic Panel Discussion on Glaucoma
Blumenthal EZ
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 441-446 (IGR: 20-4)

82323 Use of Topical Intraocular Pressure-lowering Medications in the US Population: Results From the NHANES Study 1999 to 2014
Lowry EA
Journal of Glaucoma 2019; 28: 772-776 (IGR: 20-4)

82729 Evaluating Glaucoma Treatment Effect on Intraocular Pressure Reduction Using Propensity Score Weighted Regression
Wu M
Scientific reports 2019; 9: 15496 (IGR: 20-4)

82355 Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial
Ang GS
British Journal of Ophthalmology 2020; 104: 813-821 (IGR: 20-4)

82323 Use of Topical Intraocular Pressure-lowering Medications in the US Population: Results From the NHANES Study 1999 to 2014
Chansangpetch S
Journal of Glaucoma 2019; 28: 772-776 (IGR: 20-4)

82355 Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial
Fenwick EK
British Journal of Ophthalmology 2020; 104: 813-821 (IGR: 20-4)

82588 ISOPT Hot Topic Panel Discussion on Glaucoma
Cordeiro MF
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 441-446 (IGR: 20-4)

82729 Evaluating Glaucoma Treatment Effect on Intraocular Pressure Reduction Using Propensity Score Weighted Regression
Liu M
Scientific reports 2019; 9: 15496 (IGR: 20-4)

82355 Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial
Constantinou M
British Journal of Ophthalmology 2020; 104: 813-821 (IGR: 20-4)

82588 ISOPT Hot Topic Panel Discussion on Glaucoma
Shmetterer L
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 441-446 (IGR: 20-4)

82729 Evaluating Glaucoma Treatment Effect on Intraocular Pressure Reduction Using Propensity Score Weighted Regression
Schuman JS
Scientific reports 2019; 9: 15496 (IGR: 20-4)

82323 Use of Topical Intraocular Pressure-lowering Medications in the US Population: Results From the NHANES Study 1999 to 2014
Lin SC
Journal of Glaucoma 2019; 28: 772-776 (IGR: 20-4)

82729 Evaluating Glaucoma Treatment Effect on Intraocular Pressure Reduction Using Propensity Score Weighted Regression
Wang Y
Scientific reports 2019; 9: 15496 (IGR: 20-4)

82355 Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial
Gan ATL
British Journal of Ophthalmology 2020; 104: 813-821 (IGR: 20-4)

82588 ISOPT Hot Topic Panel Discussion on Glaucoma
Levkovitch Verbin H; Harris A
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 441-446 (IGR: 20-4)

82355 Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial
Man REK
British Journal of Ophthalmology 2020; 104: 813-821 (IGR: 20-4)

82729 Evaluating Glaucoma Treatment Effect on Intraocular Pressure Reduction Using Propensity Score Weighted Regression
Lucy KA
Scientific reports 2019; 9: 15496 (IGR: 20-4)

82355 Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial
Casson RJ
British Journal of Ophthalmology 2020; 104: 813-821 (IGR: 20-4)

82729 Evaluating Glaucoma Treatment Effect on Intraocular Pressure Reduction Using Propensity Score Weighted Regression
Ishikawa H; Wollstein G
Scientific reports 2019; 9: 15496 (IGR: 20-4)

82355 Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial
Finkelstein EA; Goldberg I; Healey PR; Pesudovs K; Sanmugasundram S; Xie J; McIntosh R; Jackson J; Wells AP; White A; Martin K; Walland MJ; Crowston JG; Lamoureux EL
British Journal of Ophthalmology 2020; 104: 813-821 (IGR: 20-4)

80967 A Novel Approach to Helping People with Glaucoma Use Their Drops Routinely
McDonald JE
Optometry and Vision Science 2019; 96: 331-334 (IGR: 20-3)

81271 Pseudopemphigoid Induced by Topical Glaucoma Medications
Geerling G
Klinische Monatsblätter für Augenheilkunde 2019; 236: 762-766 (IGR: 20-3)

81436 Effect of various topical anti glaucoma drugs on cardiopulmonary system. A prospective study
Litoriya A
Romanian journal of ophthalmology 2019; 63: 142-145 (IGR: 20-3)

80486 Current management of glaucoma
Lusthaus J
The Medical journal of Australia 2019; 210: 180-187 (IGR: 20-3)

81104 Comparison of different combinations of maximum medical therapy for lowering intraocular pressure in primary open angle glaucoma: 12-month retrospective consecutive case series
Joh HJ
Japanese Journal of Ophthalmology 2019; 63: 322-327 (IGR: 20-3)

80953 Using Healthcare Databases to Refine Understanding of Exploratory Associations Between Drugs and Progression of Open-Angle Glaucoma
Wang SV
Clinical Pharmacology and Therapeutics 2019; 106: 874-883 (IGR: 20-3)

80752 Influence of Anterior Biometry on Corneal Biomechanical Stiffness of Glaucomatous Eyes Treated With Chronic Medication or Filtration Surgery
Tejwani S
Journal of Glaucoma 2019; 28: 626-632 (IGR: 20-3)

80966 Glaucoma Patient Preferences for Video Education on Eye Drop Technique
Davis SA
Optometry and Vision Science 2019; 96: 325-330 (IGR: 20-3)

81057 Prevalence of treatment with glaucoma medication in Scotland, 2010-2017
Rotchford AP
British Journal of Ophthalmology 2019; 0: (IGR: 20-3)

80966 Glaucoma Patient Preferences for Video Education on Eye Drop Technique
Carpenter DM
Optometry and Vision Science 2019; 96: 325-330 (IGR: 20-3)

81057 Prevalence of treatment with glaucoma medication in Scotland, 2010-2017
Hughes J
British Journal of Ophthalmology 2019; 0: (IGR: 20-3)

80752 Influence of Anterior Biometry on Corneal Biomechanical Stiffness of Glaucomatous Eyes Treated With Chronic Medication or Filtration Surgery
Francis M
Journal of Glaucoma 2019; 28: 626-632 (IGR: 20-3)

80967 A Novel Approach to Helping People with Glaucoma Use Their Drops Routinely
Dickinson JK
Optometry and Vision Science 2019; 96: 331-334 (IGR: 20-3)

81436 Effect of various topical anti glaucoma drugs on cardiopulmonary system. A prospective study
Tiwari US
Romanian journal of ophthalmology 2019; 63: 142-145 (IGR: 20-3)

80953 Using Healthcare Databases to Refine Understanding of Exploratory Associations Between Drugs and Progression of Open-Angle Glaucoma
Li N
Clinical Pharmacology and Therapeutics 2019; 106: 874-883 (IGR: 20-3)

80486 Current management of glaucoma
Goldberg I
The Medical journal of Australia 2019; 210: 180-187 (IGR: 20-3)

81104 Comparison of different combinations of maximum medical therapy for lowering intraocular pressure in primary open angle glaucoma: 12-month retrospective consecutive case series
Jin SW
Japanese Journal of Ophthalmology 2019; 63: 322-327 (IGR: 20-3)

81271 Pseudopemphigoid Induced by Topical Glaucoma Medications
Roth M
Klinische Monatsblätter für Augenheilkunde 2019; 236: 762-766 (IGR: 20-3)

81436 Effect of various topical anti glaucoma drugs on cardiopulmonary system. A prospective study
Pathak R
Romanian journal of ophthalmology 2019; 63: 142-145 (IGR: 20-3)

80966 Glaucoma Patient Preferences for Video Education on Eye Drop Technique
Blalock SJ
Optometry and Vision Science 2019; 96: 325-330 (IGR: 20-3)

80953 Using Healthcare Databases to Refine Understanding of Exploratory Associations Between Drugs and Progression of Open-Angle Glaucoma
Rice DS
Clinical Pharmacology and Therapeutics 2019; 106: 874-883 (IGR: 20-3)

81057 Prevalence of treatment with glaucoma medication in Scotland, 2010-2017
Agarwal PK
British Journal of Ophthalmology 2019; 0: (IGR: 20-3)

80752 Influence of Anterior Biometry on Corneal Biomechanical Stiffness of Glaucomatous Eyes Treated With Chronic Medication or Filtration Surgery
Dinakaran S
Journal of Glaucoma 2019; 28: 626-632 (IGR: 20-3)

80953 Using Healthcare Databases to Refine Understanding of Exploratory Associations Between Drugs and Progression of Open-Angle Glaucoma
Grosskreutz CL
Clinical Pharmacology and Therapeutics 2019; 106: 874-883 (IGR: 20-3)

81057 Prevalence of treatment with glaucoma medication in Scotland, 2010-2017
Tatham AJ
British Journal of Ophthalmology 2019; 0: (IGR: 20-3)

80752 Influence of Anterior Biometry on Corneal Biomechanical Stiffness of Glaucomatous Eyes Treated With Chronic Medication or Filtration Surgery
Kamath V
Journal of Glaucoma 2019; 28: 626-632 (IGR: 20-3)

80966 Glaucoma Patient Preferences for Video Education on Eye Drop Technique
Budenz DL
Optometry and Vision Science 2019; 96: 325-330 (IGR: 20-3)

80752 Influence of Anterior Biometry on Corneal Biomechanical Stiffness of Glaucomatous Eyes Treated With Chronic Medication or Filtration Surgery
Tilva B
Journal of Glaucoma 2019; 28: 626-632 (IGR: 20-3)

80953 Using Healthcare Databases to Refine Understanding of Exploratory Associations Between Drugs and Progression of Open-Angle Glaucoma
Dryja TP
Clinical Pharmacology and Therapeutics 2019; 106: 874-883 (IGR: 20-3)

80966 Glaucoma Patient Preferences for Video Education on Eye Drop Technique
Lee C
Optometry and Vision Science 2019; 96: 325-330 (IGR: 20-3)

80953 Using Healthcare Databases to Refine Understanding of Exploratory Associations Between Drugs and Progression of Open-Angle Glaucoma
Prasanna G
Clinical Pharmacology and Therapeutics 2019; 106: 874-883 (IGR: 20-3)

80752 Influence of Anterior Biometry on Corneal Biomechanical Stiffness of Glaucomatous Eyes Treated With Chronic Medication or Filtration Surgery
Das RK
Journal of Glaucoma 2019; 28: 626-632 (IGR: 20-3)

80966 Glaucoma Patient Preferences for Video Education on Eye Drop Technique
Muir KW
Optometry and Vision Science 2019; 96: 325-330 (IGR: 20-3)

80953 Using Healthcare Databases to Refine Understanding of Exploratory Associations Between Drugs and Progression of Open-Angle Glaucoma
Lii J
Clinical Pharmacology and Therapeutics 2019; 106: 874-883 (IGR: 20-3)

80752 Influence of Anterior Biometry on Corneal Biomechanical Stiffness of Glaucomatous Eyes Treated With Chronic Medication or Filtration Surgery
Shetty R
Journal of Glaucoma 2019; 28: 626-632 (IGR: 20-3)

80966 Glaucoma Patient Preferences for Video Education on Eye Drop Technique
Robin AL
Optometry and Vision Science 2019; 96: 325-330 (IGR: 20-3)

80752 Influence of Anterior Biometry on Corneal Biomechanical Stiffness of Glaucomatous Eyes Treated With Chronic Medication or Filtration Surgery
Sinha Roy A
Journal of Glaucoma 2019; 28: 626-632 (IGR: 20-3)

80966 Glaucoma Patient Preferences for Video Education on Eye Drop Technique
Sleath B
Optometry and Vision Science 2019; 96: 325-330 (IGR: 20-3)

80953 Using Healthcare Databases to Refine Understanding of Exploratory Associations Between Drugs and Progression of Open-Angle Glaucoma
Gagne JJ
Clinical Pharmacology and Therapeutics 2019; 106: 874-883 (IGR: 20-3)

79886 Changes in glaucoma medication numbers after cataract and glaucoma surgery: A nationwide population-based study
Chen HY
Medicine 2019; 98: e14128 (IGR: 20-2)

79836 Glaucoma treatment
Bluwol E
Revue du Praticien 2016; 66: 508-513 (IGR: 20-2)

80009 The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea
Choi JA; Song LD
Medicine 2019; 98: e14026 (IGR: 20-2)

79886 Changes in glaucoma medication numbers after cataract and glaucoma surgery: A nationwide population-based study
Lin CL
Medicine 2019; 98: e14128 (IGR: 20-2)

80009 The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea
Choi S
Medicine 2019; 98: e14026 (IGR: 20-2)

79886 Changes in glaucoma medication numbers after cataract and glaucoma surgery: A nationwide population-based study
Kao CH
Medicine 2019; 98: e14128 (IGR: 20-2)

80009 The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea
Park SM; Kwon JW; Jee D
Medicine 2019; 98: e14026 (IGR: 20-2)

78351 Glaucoma Drugs in the Pipeline
Kaufman PL
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 345-351 (IGR: 20-1)

78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Bengtsson B
Acta Ophthalmologica 2018; 96: 557-566 (IGR: 20-1)

79079 Glaucoma management in primary care: barriers perceived by optometrists in Scotland
Bruce G
Ophthalmic and Physiological Optics 2018; 38: 629-639 (IGR: 20-1)

78343 Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study
Lindén C
Acta Ophthalmologica 2018; 96: 567-572 (IGR: 20-1)

79243 The relationship between topical anti-glaucoma medications and the development of lacrimal drainage system obstruction
Ortiz-Basso T
Arquivos Brasileiros de Oftalmologia 2018; 81: 490-493 (IGR: 20-1)

78346 Patterns of care for glaucoma patients in Korea from 2002 to 2013 using the national health insurance service claims data
Choi S
Medicine 2018; 97: e12357 (IGR: 20-1)

78447 A cost minimisation analysis comparing iStent accompanying cataract surgery and selective laser trabeculoplasty versus topical glaucoma medications in a public healthcare setting in New Zealand
Ngan K; Fraser E
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 2181-2189 (IGR: 20-1)

78346 Patterns of care for glaucoma patients in Korea from 2002 to 2013 using the national health insurance service claims data
Choi JA
Medicine 2018; 97: e12357 (IGR: 20-1)

79079 Glaucoma management in primary care: barriers perceived by optometrists in Scotland
Tatham AJ
Ophthalmic and Physiological Optics 2018; 38: 629-639 (IGR: 20-1)

78343 Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study
Heijl A
Acta Ophthalmologica 2018; 96: 567-572 (IGR: 20-1)

78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Heijl A
Acta Ophthalmologica 2018; 96: 557-566 (IGR: 20-1)

78351 Glaucoma Drugs in the Pipeline
Mohr ME
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 345-351 (IGR: 20-1)

79243 The relationship between topical anti-glaucoma medications and the development of lacrimal drainage system obstruction
Galmarini A
Arquivos Brasileiros de Oftalmologia 2018; 81: 490-493 (IGR: 20-1)

78343 Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study
Jóhannesson G
Acta Ophthalmologica 2018; 96: 567-572 (IGR: 20-1)

78447 A cost minimisation analysis comparing iStent accompanying cataract surgery and selective laser trabeculoplasty versus topical glaucoma medications in a public healthcare setting in New Zealand
Buller S
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 2181-2189 (IGR: 20-1)

78351 Glaucoma Drugs in the Pipeline
Riccomini SP
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 345-351 (IGR: 20-1)

78346 Patterns of care for glaucoma patients in Korea from 2002 to 2013 using the national health insurance service claims data
Kwon JW
Medicine 2018; 97: e12357 (IGR: 20-1)

79243 The relationship between topical anti-glaucoma medications and the development of lacrimal drainage system obstruction
Vigo RL
Arquivos Brasileiros de Oftalmologia 2018; 81: 490-493 (IGR: 20-1)

78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Johannesson G; Andersson-Geimer S
Acta Ophthalmologica 2018; 96: 557-566 (IGR: 20-1)

78343 Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study
Aspberg J
Acta Ophthalmologica 2018; 96: 567-572 (IGR: 20-1)

78351 Glaucoma Drugs in the Pipeline
Rasmussen CA
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 345-351 (IGR: 20-1)

78343 Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study
Aspberg J
Acta Ophthalmologica 2018; 96: 567-572 (IGR: 20-1)

78346 Patterns of care for glaucoma patients in Korea from 2002 to 2013 using the national health insurance service claims data
Park SM
Medicine 2018; 97: e12357 (IGR: 20-1)

78447 A cost minimisation analysis comparing iStent accompanying cataract surgery and selective laser trabeculoplasty versus topical glaucoma medications in a public healthcare setting in New Zealand
Buller A
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 2181-2189 (IGR: 20-1)

79243 The relationship between topical anti-glaucoma medications and the development of lacrimal drainage system obstruction
Gonzalez-Barlatay JM
Arquivos Brasileiros de Oftalmologia 2018; 81: 490-493 (IGR: 20-1)

78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Andersson-Geimer S
Acta Ophthalmologica 2018; 96: 557-566 (IGR: 20-1)

78343 Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study
Aspberg J
Acta Ophthalmologica 2018; 96: 567-572 (IGR: 20-1)

79243 The relationship between topical anti-glaucoma medications and the development of lacrimal drainage system obstruction
Premoli EJ
Arquivos Brasileiros de Oftalmologia 2018; 81: 490-493 (IGR: 20-1)

78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Aspberg J; Aspberg J
Acta Ophthalmologica 2018; 96: 557-566 (IGR: 20-1)

78343 Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study
Andersson Geimer S
Acta Ophthalmologica 2018; 96: 567-572 (IGR: 20-1)

78346 Patterns of care for glaucoma patients in Korea from 2002 to 2013 using the national health insurance service claims data
Jee D
Medicine 2018; 97: e12357 (IGR: 20-1)

78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Aspberg J; Lindén C
Acta Ophthalmologica 2018; 96: 557-566 (IGR: 20-1)

78343 Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study
Bengtsson B
Acta Ophthalmologica 2018; 96: 567-572 (IGR: 20-1)

78148 Glaucomatous optic neuropathy treatment options: the promise of novel therapeutics, techniques and tools to help preserve vision
Sharif NA
Neural Regeneration Research 2018; 13: 1145-1150 (IGR: 19-4)

77714 Changes in Ocular Hypotensive Drug Usage for Glaucoma Treatment After Cataract Surgery: A Nationwide Population-based Study in Taiwan
Chang PY
Journal of Glaucoma 2018; 27: 600-605 (IGR: 19-4)

78104 Changing trends of topical anti-glaucoma medications in the Eye Hospital of Wenzhou Medical University during the past ten years
Liang YB
Chinese Journal of Ophthalmology 2018; 54: 520-525 (IGR: 19-4)

78052 Medical Management of Glaucoma in Exfoliation Syndrome
Michalik AZ; Kaufman PL
Journal of Glaucoma 2018; 27: S87-S90 (IGR: 19-4)

77714 Changes in Ocular Hypotensive Drug Usage for Glaucoma Treatment After Cataract Surgery: A Nationwide Population-based Study in Taiwan
Wang JY
Journal of Glaucoma 2018; 27: 600-605 (IGR: 19-4)

78104 Changing trends of topical anti-glaucoma medications in the Eye Hospital of Wenzhou Medical University during the past ten years
Wu HX
Chinese Journal of Ophthalmology 2018; 54: 520-525 (IGR: 19-4)

77714 Changes in Ocular Hypotensive Drug Usage for Glaucoma Treatment After Cataract Surgery: A Nationwide Population-based Study in Taiwan
Chang SW
Journal of Glaucoma 2018; 27: 600-605 (IGR: 19-4)

78104 Changing trends of topical anti-glaucoma medications in the Eye Hospital of Wenzhou Medical University during the past ten years
Liao N; Li M
Chinese Journal of Ophthalmology 2018; 54: 520-525 (IGR: 19-4)

77714 Changes in Ocular Hypotensive Drug Usage for Glaucoma Treatment After Cataract Surgery: A Nationwide Population-based Study in Taiwan
Chang YC
Journal of Glaucoma 2018; 27: 600-605 (IGR: 19-4)

78104 Changing trends of topical anti-glaucoma medications in the Eye Hospital of Wenzhou Medical University during the past ten years
Zhang Q; Wang PJ; Zheng JW; Fang AW; Qu J
Chinese Journal of Ophthalmology 2018; 54: 520-525 (IGR: 19-4)

76653 Analysis on the medication of the outpatients diagnosed with glaucoma at West China Hospital of Sichuan University
Wang P
Chinese Journal of Ophthalmology 2018; 54: 189-193 (IGR: 19-3)

76797 Simplifying "target" intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma
Sihota R
Indian Journal of Ophthalmology 2018; 66: 495-505 (IGR: 19-3)

76880 Assessment of Corneal Changes Associated with Topical Antiglaucoma Therapy Using in vivo Confocal Microscopy
Baghdasaryan E
Ophthalmic Research 2018; 0: (IGR: 19-3)

76563
Di Staso S; Agnifili L
In vivo (Athens, Greece) 2018; 32: 437-443 (IGR: 19-3)

76653 Analysis on the medication of the outpatients diagnosed with glaucoma at West China Hospital of Sichuan University
Zeng JH
Chinese Journal of Ophthalmology 2018; 54: 189-193 (IGR: 19-3)

76797 Simplifying "target" intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma
Angmo D
Indian Journal of Ophthalmology 2018; 66: 495-505 (IGR: 19-3)

76880 Assessment of Corneal Changes Associated with Topical Antiglaucoma Therapy Using in vivo Confocal Microscopy
Tepelus TC
Ophthalmic Research 2018; 0: (IGR: 19-3)

76653 Analysis on the medication of the outpatients diagnosed with glaucoma at West China Hospital of Sichuan University
Tang L
Chinese Journal of Ophthalmology 2018; 54: 189-193 (IGR: 19-3)

76797 Simplifying "target" intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma
Ramaswamy D
Indian Journal of Ophthalmology 2018; 66: 495-505 (IGR: 19-3)

76880 Assessment of Corneal Changes Associated with Topical Antiglaucoma Therapy Using in vivo Confocal Microscopy
Vickers LA
Ophthalmic Research 2018; 0: (IGR: 19-3)

76563
Ciancaglini M
In vivo (Athens, Greece) 2018; 32: 437-443 (IGR: 19-3)

76797 Simplifying "target" intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma
Dada T
Indian Journal of Ophthalmology 2018; 66: 495-505 (IGR: 19-3)

76563
Murano G
In vivo (Athens, Greece) 2018; 32: 437-443 (IGR: 19-3)

76880 Assessment of Corneal Changes Associated with Topical Antiglaucoma Therapy Using in vivo Confocal Microscopy
Huang P; Chopra V
Ophthalmic Research 2018; 0: (IGR: 19-3)

76563
Borrelli E; Borrelli E; Mastropasqua L
In vivo (Athens, Greece) 2018; 32: 437-443 (IGR: 19-3)

76880 Assessment of Corneal Changes Associated with Topical Antiglaucoma Therapy Using in vivo Confocal Microscopy
Sadda SR; Lee OL
Ophthalmic Research 2018; 0: (IGR: 19-3)

75313 Ocular Redness Measured with the Keratograph 5M in Patients Using Anti-Glaucoma Eye Drops
Pérez Bartolomé F
Seminars in Ophthalmology 2017; 0: 1-8 (IGR: 19-2)

75757 Exploring the frequency and location of prescribing errors in the use of topical glaucoma medications
Lakhani BK
Clinical and Experimental Ophthalmology 2018; 46: 616-623 (IGR: 19-2)

75310 Efficacy and safety of different regimens for primary open-angle glaucoma or ocular hypertension: a systematic review and network meta-analysis
Li F; Huang W
Acta Ophthalmologica 2018; 96: e277-e284 (IGR: 19-2)

75313 Ocular Redness Measured with the Keratograph 5M in Patients Using Anti-Glaucoma Eye Drops
Martínez de la Casa JM
Seminars in Ophthalmology 2017; 0: 1-8 (IGR: 19-2)

75757 Exploring the frequency and location of prescribing errors in the use of topical glaucoma medications
King AJ
Clinical and Experimental Ophthalmology 2018; 46: 616-623 (IGR: 19-2)

75310 Efficacy and safety of different regimens for primary open-angle glaucoma or ocular hypertension: a systematic review and network meta-analysis
Zhang X
Acta Ophthalmologica 2018; 96: e277-e284 (IGR: 19-2)

75313 Ocular Redness Measured with the Keratograph 5M in Patients Using Anti-Glaucoma Eye Drops
Arriola Villalobos P; Fernández Pérez C; Polo V; Sánchez Jean R; García Feijoó J
Seminars in Ophthalmology 2017; 0: 1-8 (IGR: 19-2)

74248 Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization
Trese MGJ
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 591-597 (IGR: 19-1)

74781 Glaucoma Medication Preferences among Glaucoma Specialists in Mexico
Lazcano-Gomez G
Journal of Current Glaucoma Practice 2017; 11: 97-100 (IGR: 19-1)

74783 Long-term Follow-up of Patients receiving Intraocular Pressure-lowering Medications as Cataract Surgery Candidates: A Case-control Study
Bontzos G
Journal of Current Glaucoma Practice 2017; 11: 107-112 (IGR: 19-1)

74081 Normal tension glaucoma management: a survey of contemporary practice
Symes RJ
Canadian Journal of Ophthalmology 2017; 52: 361-365 (IGR: 19-1)

74812 Changes in Glaucoma Medication during the Past Eight Years and Future Directions in Japan Based on an Insurance Medical Claim Database
Sakamoto M
Journal of Ophthalmology 2017; 2017: 7642049 (IGR: 19-1)

74799 Current therapeutic options and treatments in development for the management of primary open-angle glaucoma
Liebmann JM
American Journal of Managed Care 2017; 23: S279-S292 (IGR: 19-1)

74781 Glaucoma Medication Preferences among Glaucoma Specialists in Mexico
Alvarez-Ascencio D
Journal of Current Glaucoma Practice 2017; 11: 97-100 (IGR: 19-1)

74812 Changes in Glaucoma Medication during the Past Eight Years and Future Directions in Japan Based on an Insurance Medical Claim Database
Kitamura K
Journal of Ophthalmology 2017; 2017: 7642049 (IGR: 19-1)

74248 Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization
Lewis AW
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 591-597 (IGR: 19-1)

74799 Current therapeutic options and treatments in development for the management of primary open-angle glaucoma
Lee JK
American Journal of Managed Care 2017; 23: S279-S292 (IGR: 19-1)

74783 Long-term Follow-up of Patients receiving Intraocular Pressure-lowering Medications as Cataract Surgery Candidates: A Case-control Study
Agiorgiotakis M
Journal of Current Glaucoma Practice 2017; 11: 107-112 (IGR: 19-1)

74081 Normal tension glaucoma management: a survey of contemporary practice
Mikelberg FS
Canadian Journal of Ophthalmology 2017; 52: 361-365 (IGR: 19-1)

74783 Long-term Follow-up of Patients receiving Intraocular Pressure-lowering Medications as Cataract Surgery Candidates: A Case-control Study
T Detorakis E
Journal of Current Glaucoma Practice 2017; 11: 107-112 (IGR: 19-1)

74781 Glaucoma Medication Preferences among Glaucoma Specialists in Mexico
Haro-Zuno C
Journal of Current Glaucoma Practice 2017; 11: 97-100 (IGR: 19-1)

74812 Changes in Glaucoma Medication during the Past Eight Years and Future Directions in Japan Based on an Insurance Medical Claim Database
Kashiwagi K
Journal of Ophthalmology 2017; 2017: 7642049 (IGR: 19-1)

74248 Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization
Blachley TS; Stein JD
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 591-597 (IGR: 19-1)

74781 Glaucoma Medication Preferences among Glaucoma Specialists in Mexico
Turati-Acosta M
Journal of Current Glaucoma Practice 2017; 11: 97-100 (IGR: 19-1)

74248 Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization
Moroi SE
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 591-597 (IGR: 19-1)

74781 Glaucoma Medication Preferences among Glaucoma Specialists in Mexico
Garcia-Huerta M; Jimenez-Arroyo J; Castañeda-Diez R; Castillejos-Chevez A; Gonzalez-Salinas R; Dominguez-Dueñas F; Jimenez-Roman J
Journal of Current Glaucoma Practice 2017; 11: 97-100 (IGR: 19-1)

73014 Topical treatment of glaucoma: established and emerging pharmacology
Dikopf MS
Expert Opinion in Pharmacotherapy 2017; 18: 885-898 (IGR: 18-4)

72850 Rates of Intraocular Pressure Elevation and Use of Topical Antihypertensive Medication After Descemet Stripping Automated Endothelial Keratoplasty
Kaleem M
Cornea 2017; 36: 669-674 (IGR: 18-4)

72764 Use of Ocular Hypotensive Medications in Portugal: PEM Study: A Cross-sectional Nationwide Analysis
Sousa DC
Journal of Glaucoma 2017; 26: 571-576 (IGR: 18-4)

73329 Selective laser trabeculoplasty as replacement therapy in medically controlled glaucoma patients
De Keyser M
Acta Ophthalmologica 2018; 96: e577-e581 (IGR: 18-4)

72698 The Effects of Phacoemulsification on Intraocular Pressure and Topical Medication Use in Patients With Glaucoma: A Systematic Review and Meta-analysis of 3-Year Data
Armstrong JJ
Journal of Glaucoma 2017; 26: 511-522 (IGR: 18-4)

72927 Achievements and Limits of Current Medical Therapy of Glaucoma
Kalouda P
Developments in Ophthalmology 2017; 59: 1-14 (IGR: 18-4)

72996 Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma
Berdahl JP
Journal of Medical Economics 2017; 20: 760-766 (IGR: 18-4)

72730 Targeting Schlemm's Canal in the Medical Therapy of Glaucoma: Current and Future Considerations
Andrés-Guerrero V; García-Feijoo J
Advances in Therapy 2017; 34: 1049-1069 (IGR: 18-4)

72927 Achievements and Limits of Current Medical Therapy of Glaucoma
Keskini C
Developments in Ophthalmology 2017; 59: 1-14 (IGR: 18-4)

73014 Topical treatment of glaucoma: established and emerging pharmacology
Vajaranant TS
Expert Opinion in Pharmacotherapy 2017; 18: 885-898 (IGR: 18-4)

72698 The Effects of Phacoemulsification on Intraocular Pressure and Topical Medication Use in Patients With Glaucoma: A Systematic Review and Meta-analysis of 3-Year Data
Wasiuta T
Journal of Glaucoma 2017; 26: 511-522 (IGR: 18-4)

72764 Use of Ocular Hypotensive Medications in Portugal: PEM Study: A Cross-sectional Nationwide Analysis
Leal I
Journal of Glaucoma 2017; 26: 571-576 (IGR: 18-4)

73329 Selective laser trabeculoplasty as replacement therapy in medically controlled glaucoma patients
De Belder M
Acta Ophthalmologica 2018; 96: e577-e581 (IGR: 18-4)

72996 Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma
Khatana AK
Journal of Medical Economics 2017; 20: 760-766 (IGR: 18-4)

72850 Rates of Intraocular Pressure Elevation and Use of Topical Antihypertensive Medication After Descemet Stripping Automated Endothelial Keratoplasty
Ridha F
Cornea 2017; 36: 669-674 (IGR: 18-4)

72764 Use of Ocular Hypotensive Medications in Portugal: PEM Study: A Cross-sectional Nationwide Analysis
Nascimento N
Journal of Glaucoma 2017; 26: 571-576 (IGR: 18-4)

73329 Selective laser trabeculoplasty as replacement therapy in medically controlled glaucoma patients
De Belder J
Acta Ophthalmologica 2018; 96: e577-e581 (IGR: 18-4)

72698 The Effects of Phacoemulsification on Intraocular Pressure and Topical Medication Use in Patients With Glaucoma: A Systematic Review and Meta-analysis of 3-Year Data
Kiatos E
Journal of Glaucoma 2017; 26: 511-522 (IGR: 18-4)

72730 Targeting Schlemm's Canal in the Medical Therapy of Glaucoma: Current and Future Considerations
Konstas AG
Advances in Therapy 2017; 34: 1049-1069 (IGR: 18-4)

72996 Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma
Katz LJ
Journal of Medical Economics 2017; 20: 760-766 (IGR: 18-4)

72850 Rates of Intraocular Pressure Elevation and Use of Topical Antihypertensive Medication After Descemet Stripping Automated Endothelial Keratoplasty
Shwani Z
Cornea 2017; 36: 669-674 (IGR: 18-4)

73014 Topical treatment of glaucoma: established and emerging pharmacology
Edward DP
Expert Opinion in Pharmacotherapy 2017; 18: 885-898 (IGR: 18-4)

72927 Achievements and Limits of Current Medical Therapy of Glaucoma
Anastasopoulos E; Topouzis F
Developments in Ophthalmology 2017; 59: 1-14 (IGR: 18-4)

72996 Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma
Herndon L
Journal of Medical Economics 2017; 20: 760-766 (IGR: 18-4)

72764 Use of Ocular Hypotensive Medications in Portugal: PEM Study: A Cross-sectional Nationwide Analysis
Marques-Neves C
Journal of Glaucoma 2017; 26: 571-576 (IGR: 18-4)

72850 Rates of Intraocular Pressure Elevation and Use of Topical Antihypertensive Medication After Descemet Stripping Automated Endothelial Keratoplasty
Swenor B
Cornea 2017; 36: 669-674 (IGR: 18-4)

72698 The Effects of Phacoemulsification on Intraocular Pressure and Topical Medication Use in Patients With Glaucoma: A Systematic Review and Meta-analysis of 3-Year Data
Malvankar-Mehta M
Journal of Glaucoma 2017; 26: 511-522 (IGR: 18-4)

73329 Selective laser trabeculoplasty as replacement therapy in medically controlled glaucoma patients
De Groot V
Acta Ophthalmologica 2018; 96: e577-e581 (IGR: 18-4)

72996 Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma
Layton AJ
Journal of Medical Economics 2017; 20: 760-766 (IGR: 18-4)

72764 Use of Ocular Hypotensive Medications in Portugal: PEM Study: A Cross-sectional Nationwide Analysis
Tuulonen A
Journal of Glaucoma 2017; 26: 571-576 (IGR: 18-4)

72850 Rates of Intraocular Pressure Elevation and Use of Topical Antihypertensive Medication After Descemet Stripping Automated Endothelial Keratoplasty
Goshe J
Cornea 2017; 36: 669-674 (IGR: 18-4)

72698 The Effects of Phacoemulsification on Intraocular Pressure and Topical Medication Use in Patients With Glaucoma: A Systematic Review and Meta-analysis of 3-Year Data
Hutnik CML
Journal of Glaucoma 2017; 26: 511-522 (IGR: 18-4)

72996 Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma
Yu TM
Journal of Medical Economics 2017; 20: 760-766 (IGR: 18-4)

72850 Rates of Intraocular Pressure Elevation and Use of Topical Antihypertensive Medication After Descemet Stripping Automated Endothelial Keratoplasty
Singh A
Cornea 2017; 36: 669-674 (IGR: 18-4)

72764 Use of Ocular Hypotensive Medications in Portugal: PEM Study: A Cross-sectional Nationwide Analysis
Abegão Pinto L
Journal of Glaucoma 2017; 26: 571-576 (IGR: 18-4)

72996 Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma
Bauer MJ; Cantor LB
Journal of Medical Economics 2017; 20: 760-766 (IGR: 18-4)

71570 Glaucoma treatment trends: a review
Conlon R; Saheb H; Ahmed II
Canadian Journal of Ophthalmology 2017; 52: 114-124 (IGR: 18-3)

70296 An Overview of Treatment Methods for Primary Angle Closure
Anwar F
Seminars in Ophthalmology 2017; 32: 82-85 (IGR: 18-2)

70593 Diplopia in Medically and Surgically Treated Patients with Glaucoma
Sun PY
Ophthalmology 2017; 124: 257-262 (IGR: 18-2)

70851 Maximizing cost-effectiveness by adjusting treatment strategy according to glaucoma severity
Guedes RA
Medicine 2016; 95: e5745 (IGR: 18-2)

70788 Management of glaucoma in pregnancy: risks or choices, a dilemma?
Sethi HS
International Journal of Ophthalmology 2016; 9: 1684-1690 (IGR: 18-2)

70252 Primary open-angle glaucoma
Weinreb RN
Nature reviews. Disease primers 2016; 2: 16067 (IGR: 18-2)

70482 Glaucoma-Intraocular Pressure Reduction
Huang AS
Handb Exp Pharmacol 2017; 242: 181-207 (IGR: 18-2)

70555 Preoperative therapy switch before glaucoma filtration surgery : Influence of the systemic antiglaucomatous and local antiphlogistic therapy on the intraocular pressure
Oberacher-Velten I
Ophthalmologe 2017; 114: 632-638 (IGR: 18-2)

70717 Frequency of unplanned interventions in patients attending for a presumed routine glaucoma follow-up appointment
Calafati J
Canadian Journal of Ophthalmology 2016; 51: 426-430 (IGR: 18-2)

70629 Medical Management of Glaucoma in the 21st Century from a Canadian Perspective
Harasymowycz P
Journal of Ophthalmology 2016; 2016: 6509809 (IGR: 18-2)

70178 Possibilities and limitations of eye drops for glaucoma therapy
Lanzl IM
Ophthalmologe 2016; 113: 824-832 (IGR: 18-2)

70252 Primary open-angle glaucoma
Leung CK
Nature reviews. Disease primers 2016; 2: 16067 (IGR: 18-2)

70717 Frequency of unplanned interventions in patients attending for a presumed routine glaucoma follow-up appointment
Pradhan ZS
Canadian Journal of Ophthalmology 2016; 51: 426-430 (IGR: 18-2)

70851 Maximizing cost-effectiveness by adjusting treatment strategy according to glaucoma severity
Guedes VM
Medicine 2016; 95: e5745 (IGR: 18-2)

70788 Management of glaucoma in pregnancy: risks or choices, a dilemma?
Naik M
International Journal of Ophthalmology 2016; 9: 1684-1690 (IGR: 18-2)

70482 Glaucoma-Intraocular Pressure Reduction
Minasyan L
Handb Exp Pharmacol 2017; 242: 181-207 (IGR: 18-2)

70555 Preoperative therapy switch before glaucoma filtration surgery : Influence of the systemic antiglaucomatous and local antiphlogistic therapy on the intraocular pressure
Zeman F
Ophthalmologe 2017; 114: 632-638 (IGR: 18-2)

70296 An Overview of Treatment Methods for Primary Angle Closure
Turalba A
Seminars in Ophthalmology 2017; 32: 82-85 (IGR: 18-2)

70593 Diplopia in Medically and Surgically Treated Patients with Glaucoma
Leske DA
Ophthalmology 2017; 124: 257-262 (IGR: 18-2)

70629 Medical Management of Glaucoma in the 21st Century from a Canadian Perspective
Birt C
Journal of Ophthalmology 2016; 2016: 6509809 (IGR: 18-2)

70178 Possibilities and limitations of eye drops for glaucoma therapy
Poimenidou M
Ophthalmologe 2016; 113: 824-832 (IGR: 18-2)

70555 Preoperative therapy switch before glaucoma filtration surgery : Influence of the systemic antiglaucomatous and local antiphlogistic therapy on the intraocular pressure
Lehmann F
Ophthalmologe 2017; 114: 632-638 (IGR: 18-2)

70178 Possibilities and limitations of eye drops for glaucoma therapy
Spaeth GL
Ophthalmologe 2016; 113: 824-832 (IGR: 18-2)

70252 Primary open-angle glaucoma
Crowston JG
Nature reviews. Disease primers 2016; 2: 16067 (IGR: 18-2)

70717 Frequency of unplanned interventions in patients attending for a presumed routine glaucoma follow-up appointment
Birt CM
Canadian Journal of Ophthalmology 2016; 51: 426-430 (IGR: 18-2)

70593 Diplopia in Medically and Surgically Treated Patients with Glaucoma
Holmes JM
Ophthalmology 2017; 124: 257-262 (IGR: 18-2)

70482 Glaucoma-Intraocular Pressure Reduction
Weinreb RN
Handb Exp Pharmacol 2017; 242: 181-207 (IGR: 18-2)

70851 Maximizing cost-effectiveness by adjusting treatment strategy according to glaucoma severity
Gomes CE
Medicine 2016; 95: e5745 (IGR: 18-2)

70629 Medical Management of Glaucoma in the 21st Century from a Canadian Perspective
Gooi P
Journal of Ophthalmology 2016; 2016: 6509809 (IGR: 18-2)

70788 Management of glaucoma in pregnancy: risks or choices, a dilemma?
Gupta VS
International Journal of Ophthalmology 2016; 9: 1684-1690 (IGR: 18-2)

70629 Medical Management of Glaucoma in the 21st Century from a Canadian Perspective
Heckler L
Journal of Ophthalmology 2016; 2016: 6509809 (IGR: 18-2)

70851 Maximizing cost-effectiveness by adjusting treatment strategy according to glaucoma severity
Chaoubah A
Medicine 2016; 95: e5745 (IGR: 18-2)

70252 Primary open-angle glaucoma
Medeiros FA
Nature reviews. Disease primers 2016; 2: 16067 (IGR: 18-2)

70555 Preoperative therapy switch before glaucoma filtration surgery : Influence of the systemic antiglaucomatous and local antiphlogistic therapy on the intraocular pressure
Barth T
Ophthalmologe 2017; 114: 632-638 (IGR: 18-2)

70593 Diplopia in Medically and Surgically Treated Patients with Glaucoma
Khanna CL
Ophthalmology 2017; 124: 257-262 (IGR: 18-2)

70629 Medical Management of Glaucoma in the 21st Century from a Canadian Perspective
Hutnik C
Journal of Ophthalmology 2016; 2016: 6509809 (IGR: 18-2)

70555 Preoperative therapy switch before glaucoma filtration surgery : Influence of the systemic antiglaucomatous and local antiphlogistic therapy on the intraocular pressure
Peters P
Ophthalmologe 2017; 114: 632-638 (IGR: 18-2)

70252 Primary open-angle glaucoma
Friedman DS; Wiggs JL
Nature reviews. Disease primers 2016; 2: 16067 (IGR: 18-2)

70629 Medical Management of Glaucoma in the 21st Century from a Canadian Perspective
Jinapriya D
Journal of Ophthalmology 2016; 2016: 6509809 (IGR: 18-2)

70555 Preoperative therapy switch before glaucoma filtration surgery : Influence of the systemic antiglaucomatous and local antiphlogistic therapy on the intraocular pressure
Helbig H; Greslechner R
Ophthalmologe 2017; 114: 632-638 (IGR: 18-2)

70252 Primary open-angle glaucoma
Martin KR
Nature reviews. Disease primers 2016; 2: 16067 (IGR: 18-2)

70629 Medical Management of Glaucoma in the 21st Century from a Canadian Perspective
Shuba L; Yan D; Day R
Journal of Ophthalmology 2016; 2016: 6509809 (IGR: 18-2)

69262 Pay attention to the fine management of the diagnosis and treatment of glaucoma
Wang NL
Chinese Journal of Ophthalmology 2016; 52: 401-403 (IGR: 18-1)

69307 Problems With Large Joints: Knee Conditions
Porter AS
FP essentials 2016; 446: 11-18 (IGR: 18-1)

69223 Eye Conditions in Older Adults: Open-Angle Glaucoma
Iroku-Malize T
FP essentials 2016; 445: 11-16 (IGR: 18-1)

68947 Predictors, Resource Utilization, and Short-term Costs of Laser Trabeculoplasty Versus Medication Management in Open-Angle Glaucoma
Schultz NM
American Journal of Ophthalmology 2016; 168: 78-85 (IGR: 18-1)

69268 Novel therapeutic targets for reduction of intraocular pressure in primary open angle glaucoma
Mao WM
Chinese Journal of Ophthalmology 2016; 52: 471-475 (IGR: 18-1)

68862 Pediatric Glaucoma: Pharmacotherapeutic Options
Samant M
Pediatric Drugs 2016; 18: 209-219 (IGR: 18-1)

68947 Predictors, Resource Utilization, and Short-term Costs of Laser Trabeculoplasty Versus Medication Management in Open-Angle Glaucoma
Wong WB
American Journal of Ophthalmology 2016; 168: 78-85 (IGR: 18-1)

69268 Novel therapeutic targets for reduction of intraocular pressure in primary open angle glaucoma
Liu Y
Chinese Journal of Ophthalmology 2016; 52: 471-475 (IGR: 18-1)

68862 Pediatric Glaucoma: Pharmacotherapeutic Options
Medsinge A
Pediatric Drugs 2016; 18: 209-219 (IGR: 18-1)

69223 Eye Conditions in Older Adults: Open-Angle Glaucoma
Kirsch S
FP essentials 2016; 445: 11-16 (IGR: 18-1)

68862 Pediatric Glaucoma: Pharmacotherapeutic Options
Nischal KK
Pediatric Drugs 2016; 18: 209-219 (IGR: 18-1)

69268 Novel therapeutic targets for reduction of intraocular pressure in primary open angle glaucoma
Wordinger YH
Chinese Journal of Ophthalmology 2016; 52: 471-475 (IGR: 18-1)

68947 Predictors, Resource Utilization, and Short-term Costs of Laser Trabeculoplasty Versus Medication Management in Open-Angle Glaucoma
Coleman AL; Malone DC
American Journal of Ophthalmology 2016; 168: 78-85 (IGR: 18-1)

69268 Novel therapeutic targets for reduction of intraocular pressure in primary open angle glaucoma
Clark AF; Pang IH
Chinese Journal of Ophthalmology 2016; 52: 471-475 (IGR: 18-1)

67542 Network Meta-analysis for Clinical Practice Guidelines: A Case Study on First-Line Medical Therapies for Primary Open-Angle Glaucoma
Rouse B
Annals of Internal Medicine 2016; 164: 674-682 (IGR: 17-4)

67207 Management of advanced glaucoma: characterization and monitoring
De Moraes CG
Survey of Ophthalmology 2016; 61: 597-615 (IGR: 17-4)

67101 Ocular Pharmacology
Rehovsky J
Insight 2016; 41: 17-21 (IGR: 17-4)

67542 Network Meta-analysis for Clinical Practice Guidelines: A Case Study on First-Line Medical Therapies for Primary Open-Angle Glaucoma
Cipriani A
Annals of Internal Medicine 2016; 164: 674-682 (IGR: 17-4)

67207 Management of advanced glaucoma: characterization and monitoring
Liebmann JM; Medeiros FA
Survey of Ophthalmology 2016; 61: 597-615 (IGR: 17-4)

67542 Network Meta-analysis for Clinical Practice Guidelines: A Case Study on First-Line Medical Therapies for Primary Open-Angle Glaucoma
Shi Q
Annals of Internal Medicine 2016; 164: 674-682 (IGR: 17-4)

67207 Management of advanced glaucoma: characterization and monitoring
Weinreb RN
Survey of Ophthalmology 2016; 61: 597-615 (IGR: 17-4)

67542 Network Meta-analysis for Clinical Practice Guidelines: A Case Study on First-Line Medical Therapies for Primary Open-Angle Glaucoma
Coleman AL; Dickersin K; Li T
Annals of Internal Medicine 2016; 164: 674-682 (IGR: 17-4)

66330 Glaucoma -state of the art and perspectives on treatment
Wójcik-Gryciuk A
Restorative Neurology and Neuroscience 2015; 34: 107-123 (IGR: 17-3)

65948 Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial
Vickerstaff V
Trials 2015; 16: 517 (IGR: 17-3)

66275 Selective laser trabeculoplasty compared with medical treatment for the initial management of open angle glaucoma or ocular hypertension
Pérez E
Medwave 2015; 15: e6337 (IGR: 17-3)

66324 RiGOR: a prospective observational study comparing the effectiveness of treatment strategies for open-angle glaucoma
Coleman AL
Journal of comparative effectiveness research 2016; 5: 65-78 (IGR: 17-3)

66482 Complexities of Medical Glaucoma Therapy - the Elderly Patient in Focus
Dietlein TS
Klinische Monatsblätter für Augenheilkunde 2016; 233: 138-142 (IGR: 17-3)

66322 Impact of treatment strategies for open angle glaucoma on intraocular pressure: the RiGOR study
Coleman AL
Journal of comparative effectiveness research 2016; 5: 87-98 (IGR: 17-3)

66284 Intraocular pressure control in patients with primary open angle glaucoma and diabetes mellitus
Torres-Martínez LA
Archivos de la Sociedad Española de Oftalmologia 2016; 91: 125-129 (IGR: 17-3)

66211 Update on the Medical Treatment of Primary Open-Angle Glaucoma
Cheema A
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2016; 5: 51-58 (IGR: 17-3)

66323 Practice patterns and treatment changes for open-angle glaucoma: the RiGOR study
Coleman AL
Journal of comparative effectiveness research 2016; 5: 79-85 (IGR: 17-3)

66324 RiGOR: a prospective observational study comparing the effectiveness of treatment strategies for open-angle glaucoma
Lum FC
Journal of comparative effectiveness research 2016; 5: 65-78 (IGR: 17-3)

66482 Complexities of Medical Glaucoma Therapy - the Elderly Patient in Focus
Rosentreter A
Klinische Monatsblätter für Augenheilkunde 2016; 233: 138-142 (IGR: 17-3)

66330 Glaucoma -state of the art and perspectives on treatment
Skup M
Restorative Neurology and Neuroscience 2015; 34: 107-123 (IGR: 17-3)

66284 Intraocular pressure control in patients with primary open angle glaucoma and diabetes mellitus
Lara-Huerta SF
Archivos de la Sociedad Española de Oftalmologia 2016; 91: 125-129 (IGR: 17-3)

66322 Impact of treatment strategies for open angle glaucoma on intraocular pressure: the RiGOR study
Lum FC
Journal of comparative effectiveness research 2016; 5: 87-98 (IGR: 17-3)

66211 Update on the Medical Treatment of Primary Open-Angle Glaucoma
Chang RT
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2016; 5: 51-58 (IGR: 17-3)

66323 Practice patterns and treatment changes for open-angle glaucoma: the RiGOR study
Lum FC
Journal of comparative effectiveness research 2016; 5: 79-85 (IGR: 17-3)

65948 Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial
Ambler G
Trials 2015; 16: 517 (IGR: 17-3)

66275 Selective laser trabeculoplasty compared with medical treatment for the initial management of open angle glaucoma or ocular hypertension
Rada G
Medwave 2015; 15: e6337 (IGR: 17-3)

66324 RiGOR: a prospective observational study comparing the effectiveness of treatment strategies for open-angle glaucoma
Velentgas P
Journal of comparative effectiveness research 2016; 5: 65-78 (IGR: 17-3)

66211 Update on the Medical Treatment of Primary Open-Angle Glaucoma
Shrivastava A
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2016; 5: 51-58 (IGR: 17-3)

66284 Intraocular pressure control in patients with primary open angle glaucoma and diabetes mellitus
Babayán-Mena JI
Archivos de la Sociedad Española de Oftalmologia 2016; 91: 125-129 (IGR: 17-3)

66322 Impact of treatment strategies for open angle glaucoma on intraocular pressure: the RiGOR study
Velentgas P
Journal of comparative effectiveness research 2016; 5: 87-98 (IGR: 17-3)

65948 Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial
Bunce C
Trials 2015; 16: 517 (IGR: 17-3)

66275 Selective laser trabeculoplasty compared with medical treatment for the initial management of open angle glaucoma or ocular hypertension
Maul E
Medwave 2015; 15: e6337 (IGR: 17-3)

66323 Practice patterns and treatment changes for open-angle glaucoma: the RiGOR study
Velentgas P
Journal of comparative effectiveness research 2016; 5: 79-85 (IGR: 17-3)

66330 Glaucoma -state of the art and perspectives on treatment
Waleszczyk WJ
Restorative Neurology and Neuroscience 2015; 34: 107-123 (IGR: 17-3)

66482 Complexities of Medical Glaucoma Therapy - the Elderly Patient in Focus
Lappas A
Klinische Monatsblätter für Augenheilkunde 2016; 233: 138-142 (IGR: 17-3)

66323 Practice patterns and treatment changes for open-angle glaucoma: the RiGOR study
Su Z
Journal of comparative effectiveness research 2016; 5: 79-85 (IGR: 17-3)

66211 Update on the Medical Treatment of Primary Open-Angle Glaucoma
Singh K
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2016; 5: 51-58 (IGR: 17-3)

66324 RiGOR: a prospective observational study comparing the effectiveness of treatment strategies for open-angle glaucoma
Campion D
Journal of comparative effectiveness research 2016; 5: 65-78 (IGR: 17-3)

66322 Impact of treatment strategies for open angle glaucoma on intraocular pressure: the RiGOR study
Su Z
Journal of comparative effectiveness research 2016; 5: 87-98 (IGR: 17-3)

65948 Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial
Xing W
Trials 2015; 16: 517 (IGR: 17-3)

66284 Intraocular pressure control in patients with primary open angle glaucoma and diabetes mellitus
Herrero-Herrera S
Archivos de la Sociedad Española de Oftalmologia 2016; 91: 125-129 (IGR: 17-3)

65948 Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial
Gazzard G
Trials 2015; 16: 517 (IGR: 17-3)

66322 Impact of treatment strategies for open angle glaucoma on intraocular pressure: the RiGOR study
Gliklich RE
Journal of comparative effectiveness research 2016; 5: 87-98 (IGR: 17-3)

66324 RiGOR: a prospective observational study comparing the effectiveness of treatment strategies for open-angle glaucoma
Su Z
Journal of comparative effectiveness research 2016; 5: 65-78 (IGR: 17-3)

66323 Practice patterns and treatment changes for open-angle glaucoma: the RiGOR study
Gliklich RE
Journal of comparative effectiveness research 2016; 5: 79-85 (IGR: 17-3)

66322 Impact of treatment strategies for open angle glaucoma on intraocular pressure: the RiGOR study

Journal of comparative effectiveness research 2016; 5: 87-98 (IGR: 17-3)

66323 Practice patterns and treatment changes for open-angle glaucoma: the RiGOR study

Journal of comparative effectiveness research 2016; 5: 79-85 (IGR: 17-3)

65948 Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial

Trials 2015; 16: 517 (IGR: 17-3)

66324 RiGOR: a prospective observational study comparing the effectiveness of treatment strategies for open-angle glaucoma
Gliklich RE;
Journal of comparative effectiveness research 2016; 5: 65-78 (IGR: 17-3)

60974 Impact of initial topical medical therapy on short-term quality of life in newly diagnosed patients with primary glaucoma
Arora V
Indian Journal of Ophthalmology 2015; 63: 511-515 (IGR: 17-1)

61561 Association between Glaucoma Medication Usage and Dry Eye in Taiwan
Chen HY
Optometry and Vision Science 2015; 92: e227-e232 (IGR: 17-1)

61729 Subsequent Receipt of Interventions for Glaucoma Among a Nationwide Sample of Patients Who Underwent Laser Peripheral Iridotomy
Bansal S
American Journal of Ophthalmology 2015; 160: 275-282.e4 (IGR: 17-1)

61046 The use of ocular hypotensive drugs for glaucoma treatment: changing trend in Taiwan from 1997 to 2007
Lin JC
Journal of Glaucoma 2015; 24: 364-371 (IGR: 17-1)

61006 Present and New Treatment Strategies in the Management of Glaucoma
Kolko M
Open Ophthalmology Journal 2015; 9: 89-100 (IGR: 17-1)

61482 Carbonic anhydrase inhibitors as fourth drug in primary glaucomas: Is it worth it?
Juncal VR
Canadian Journal of Ophthalmology 2015; 50: 297-301 (IGR: 17-1)

61039 Management of exfoliative glaucoma: challenges and solutions
Holló G
Clinical Ophthalmology 2015; 9: 907-919 (IGR: 17-1)

60974 Impact of initial topical medical therapy on short-term quality of life in newly diagnosed patients with primary glaucoma
Bali SJ
Indian Journal of Ophthalmology 2015; 63: 511-515 (IGR: 17-1)

61482 Carbonic anhydrase inhibitors as fourth drug in primary glaucomas: Is it worth it?
Abdo Jorge F
Canadian Journal of Ophthalmology 2015; 50: 297-301 (IGR: 17-1)

61561 Association between Glaucoma Medication Usage and Dry Eye in Taiwan
Lin CL
Optometry and Vision Science 2015; 92: e227-e232 (IGR: 17-1)

61039 Management of exfoliative glaucoma: challenges and solutions
Katsanos A
Clinical Ophthalmology 2015; 9: 907-919 (IGR: 17-1)

61729 Subsequent Receipt of Interventions for Glaucoma Among a Nationwide Sample of Patients Who Underwent Laser Peripheral Iridotomy
Balakrishnan SA
American Journal of Ophthalmology 2015; 160: 275-282.e4 (IGR: 17-1)

61039 Management of exfoliative glaucoma: challenges and solutions
Konstas AG
Clinical Ophthalmology 2015; 9: 907-919 (IGR: 17-1)

60974 Impact of initial topical medical therapy on short-term quality of life in newly diagnosed patients with primary glaucoma
Gupta SK
Indian Journal of Ophthalmology 2015; 63: 511-515 (IGR: 17-1)

61482 Carbonic anhydrase inhibitors as fourth drug in primary glaucomas: Is it worth it?
Paranhos A
Canadian Journal of Ophthalmology 2015; 50: 297-301 (IGR: 17-1)

61729 Subsequent Receipt of Interventions for Glaucoma Among a Nationwide Sample of Patients Who Underwent Laser Peripheral Iridotomy
Blachley T
American Journal of Ophthalmology 2015; 160: 275-282.e4 (IGR: 17-1)

61561 Association between Glaucoma Medication Usage and Dry Eye in Taiwan
Tsai YY
Optometry and Vision Science 2015; 92: e227-e232 (IGR: 17-1)

60974 Impact of initial topical medical therapy on short-term quality of life in newly diagnosed patients with primary glaucoma
Vashisht P
Indian Journal of Ophthalmology 2015; 63: 511-515 (IGR: 17-1)

61482 Carbonic anhydrase inhibitors as fourth drug in primary glaucomas: Is it worth it?
Santos Prata T
Canadian Journal of Ophthalmology 2015; 50: 297-301 (IGR: 17-1)

61561 Association between Glaucoma Medication Usage and Dry Eye in Taiwan
Kao CH
Optometry and Vision Science 2015; 92: e227-e232 (IGR: 17-1)

61729 Subsequent Receipt of Interventions for Glaucoma Among a Nationwide Sample of Patients Who Underwent Laser Peripheral Iridotomy
Weizer JS; Lee PP
American Journal of Ophthalmology 2015; 160: 275-282.e4 (IGR: 17-1)

60974 Impact of initial topical medical therapy on short-term quality of life in newly diagnosed patients with primary glaucoma
Agarwal T
Indian Journal of Ophthalmology 2015; 63: 511-515 (IGR: 17-1)

61729 Subsequent Receipt of Interventions for Glaucoma Among a Nationwide Sample of Patients Who Underwent Laser Peripheral Iridotomy
Stein JD
American Journal of Ophthalmology 2015; 160: 275-282.e4 (IGR: 17-1)

60974 Impact of initial topical medical therapy on short-term quality of life in newly diagnosed patients with primary glaucoma
Sreenivas V; Dada T
Indian Journal of Ophthalmology 2015; 63: 511-515 (IGR: 17-1)

59993 Exciting directions in glaucoma
Rasmussen CA
Canadian Journal of Ophthalmology 2014; 49: 534-543 (IGR: 16-4)

60271 Pharmacotherapy of glaucoma
Schmidl D
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 63-77 (IGR: 16-4)

60287 Medical therapy for glaucoma: what to add after a prostaglandin analogs?
Tanna AP
Current Opinions in Ophthalmology 2015; 26: 116-120 (IGR: 16-4)

60583 Protocol-driven adjustment of ocular hypotensive medication in patients at low risk of conversion to glaucoma
Chan PP
British Journal of Ophthalmology 2015; 99: 1245-1250 (IGR: 16-4)

60594 Comparative Cost-effectiveness of the Baerveldt Implant, Trabeculectomy With Mitomycin, and Medical Treatment
Kaplan RI
JAMA ophthalmology 2015; 0: (IGR: 16-4)

60122 Different strategies and cost-effectiveness in the treatment of primary open angle glaucoma
Ting NS
ClinicoEconomics and outcomes research : CEOR 2014; 6: 523-530 (IGR: 16-4)

60594 Comparative Cost-effectiveness of the Baerveldt Implant, Trabeculectomy With Mitomycin, and Medical Treatment
De Moraes CG
JAMA ophthalmology 2015; 0: (IGR: 16-4)

60122 Different strategies and cost-effectiveness in the treatment of primary open angle glaucoma
Li Yim JF
ClinicoEconomics and outcomes research : CEOR 2014; 6: 523-530 (IGR: 16-4)

60287 Medical therapy for glaucoma: what to add after a prostaglandin analogs?
Lin AB
Current Opinions in Ophthalmology 2015; 26: 116-120 (IGR: 16-4)

60271 Pharmacotherapy of glaucoma
Schmetterer L
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 63-77 (IGR: 16-4)

59993 Exciting directions in glaucoma
Kaufman PL
Canadian Journal of Ophthalmology 2014; 49: 534-543 (IGR: 16-4)

60583 Protocol-driven adjustment of ocular hypotensive medication in patients at low risk of conversion to glaucoma
Leung CK
British Journal of Ophthalmology 2015; 99: 1245-1250 (IGR: 16-4)

60271 Pharmacotherapy of glaucoma
Garhöfer G
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 63-77 (IGR: 16-4)

60583 Protocol-driven adjustment of ocular hypotensive medication in patients at low risk of conversion to glaucoma
Chiu V
British Journal of Ophthalmology 2015; 99: 1245-1250 (IGR: 16-4)

60122 Different strategies and cost-effectiveness in the treatment of primary open angle glaucoma
Ng JY
ClinicoEconomics and outcomes research : CEOR 2014; 6: 523-530 (IGR: 16-4)

60594 Comparative Cost-effectiveness of the Baerveldt Implant, Trabeculectomy With Mitomycin, and Medical Treatment
Cioffi GA
JAMA ophthalmology 2015; 0: (IGR: 16-4)

60271 Pharmacotherapy of glaucoma
Popa-Cherecheanu A
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 63-77 (IGR: 16-4)

60583 Protocol-driven adjustment of ocular hypotensive medication in patients at low risk of conversion to glaucoma
Gangwani R
British Journal of Ophthalmology 2015; 99: 1245-1250 (IGR: 16-4)

60594 Comparative Cost-effectiveness of the Baerveldt Implant, Trabeculectomy With Mitomycin, and Medical Treatment
Al-Aswad LA; Blumberg DM
JAMA ophthalmology 2015; 0: (IGR: 16-4)

60583 Protocol-driven adjustment of ocular hypotensive medication in patients at low risk of conversion to glaucoma
Sharma A; So S; Congdon N
British Journal of Ophthalmology 2015; 99: 1245-1250 (IGR: 16-4)

58964 Alterations of intraocular pressure in comparison of self- and external-administered topical antiglaucomatosa during diurnal intraocular pressure measurements
Böhm MR; Lill TM; Eter N; Prokosch-Willing V
Klinische Monatsblätter für Augenheilkunde 2014; 231: 810-817 (IGR: 16-3)

59628 Guidelines for treatment of chronic primary angle-closure glaucoma
Muñoz-Negrete FJ; González-Martín-Moro J; Casas-Llera P; Urcelay-Segura JL; Rebolleda G; Ussa F; Güerri Monclús N; Méndez Hernández C; Moreno-Montañés J; Villegas Pérez MP; Pablo LE; Garc
Archivos de la Sociedad Española de Oftalmologia 2015; 90: 119-138 (IGR: 16-3)

57524 New perspectives on target intraocular pressure
Clement CI; Bhartiya S; Shaarawy T
Survey of Ophthalmology 2014; 59: 615-626 (IGR: 16-2)

57304 New directions in the treatment of normal tension glaucoma
Song BJ; Caprioli J
Indian Journal of Ophthalmology 2014; 62: 529-537 (IGR: 16-2)

57254 Glaucoma prescribing trends in England 2000 to 2012
Connor AJ; Fraser SG
Eye 2014; 28: 863-869 (IGR: 16-2)

57281 A Prospective Research Study of Anti-Glaucoma Drugs Prescribing, Utilization Pattern and Adverse Drug Reaction Recording in a University Hospital
Alaei M; Najmi AK; Kausar H; Akhtar M
Drug research 2015; 65: 164-168 (IGR: 16-2)

56656 Managing adverse effects of glaucoma medications
Inoue K
Clinical Ophthalmology 2014; 8: 903-913 (IGR: 16-1)

55178 Glaucoma today: detection and therapeutic progress
Baudouin C; Denoyer A; Rostène W
Biologie aujourd'hui 2013; 207: 87-95 (IGR: 15-4)

55584 Glaucoma management: relative value and place in therapy of available drug treatments
Sambhara D; Aref AA
Therapeutic advances in chronic disease 2014; 5: 30-43 (IGR: 15-4)

54717 Glaucoma: present challenges and future trends
Bettin P; Di Matteo F
Ophthalmic Research 2013; 50: 197-208 (IGR: 15-3)

53820 Current treatment strategies for age-related ocular conditions
Akpek EK; Smith RA
American Journal of Managed Care 2013; 19: s76-84 (IGR: 15-2)

54041 Glaucoma patients and contact lenses--how to fit--how to treat?
Salopek-Rabatić J; Pavan J; Kastelan S; Rabatić L
Collegium Antropologicum 2013; 37: 195-198 (IGR: 15-2)

52602 Advanced glaucoma: management pearls
Gessesse GW; Damji KF
Middle East African Journal of Ophthalmology 2013; 20: 131-141 (IGR: 15-1)

52984 Central corneal thickness and glaucoma treatment: an italian multicenter cross-sectional study
Iester M; Telani S; Brusini P; Rolle T; Fogagnolo P; Martini E; Milano G; Paoli And The Italian Glaucoma Register D
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 469-473 (IGR: 15-1)

53224 Intraocular pressure reduction with topical medications and progression of normal-tension glaucoma: a 12-year mean follow-up study
Kim M; Kim DM; Park KH; Kim TW; Jeoung JW; Kim SH
Acta Ophthalmologica 2013; 91: e270-e275 (IGR: 15-1)

52813 Glaucoma: pharmacological implications
Rieger-Reyes C; Rubio-Galán FJ
Semergen / Sociedad Española de Medicina Rural y Generalista 2013; 39: 26-33 (IGR: 15-1)

52627 Pleiotropic effects in local drug treatment for glaucoma
Erb C
Klinische Monatsblätter für Augenheilkunde 2013; 230: 141-145 (IGR: 15-1)

52836 Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the U.S. Preventive Services Task Force
Boland MV; Ervin AM; Friedman DS; Jampel HD; Hawkins BS; Vollenweider D; Chelladurai Y; Ward D; Suarez-Cuervo C; Robinson KA
Annals of Internal Medicine 2013; 158: 271-279 (IGR: 15-1)

53004 Glaucoma medications
Chae B; Cakiner-Egilmez T; Desai M
Insight 2013; 38: 5-9 (IGR: 15-1)

52557 Drug use in primary open angle glaucoma: A prospective study at a tertiary care teaching hospital
Yadav AK; Patel V
Indian Journal of Pharmacology 2013; 45: 117-120 (IGR: 15-1)

52735 Glaucoma management in Sweden -- results from a nationwide survey
Lindén C; Bengtsson B; Alm A; Calissendorff B; Eckerlund I; Heijl A
Acta Ophthalmologica 2013; 91: 20-24 (IGR: 15-1)

51755 Topical intraocular pressure therapy effects on pregnancy
Mendez-Hernandez C; Garcia-Feijoo J; Saenz-Frances F; Santos-Bueso E; Martinez-de-la-Casa JM; Megias AV; Fernández-Vidal AM; Garcia-Sanchez J
Clinical Ophthalmology 2012; 6: 1629-1632 (IGR: 14-4)

51774 Current primary open-angle glaucoma treatments and future directions
Beidoe G; Mousa SA
Clinical Ophthalmology 2012; 6: 1699-1707 (IGR: 14-4)

51707 Pharmacological management of ocular hypertension: current approaches and future prospective
Bucolo C; Salomone S; Drago F; Reibaldi M; Longo A; Uva MG
Current opinion in pharmacology 2013; 13: 50-55 (IGR: 14-4)

51864 Ophthalmic drugs as part of polypharmacy in nursing home residents with glaucoma
Huber M; Kölzsch M; Stahlmann R; Hofmann W; Bolbrinker J; Dräger D; Kreutz R
Drugs and Aging 2013; 30: 31-38 (IGR: 14-4)

51260 Medical versus surgical interventions for open angle glaucoma
Burr J; Azuara-Blanco A; Avenell A; Tuulonen A
Cochrane Database of Systematic Reviews 2012; 9: CD004399 (IGR: 14-3)

50688 Long-term medical management of primary open-angle glaucoma and ocular hypertension in the UK: optimizing cost-effectiveness and clinic resources by minimizing therapy switches
Orme M; Collins S; Loftus J
Journal of Glaucoma 2012; 21: 433-449 (IGR: 14-3)

50346 A study of initial therapy for glaucoma in southern India: India Glaucoma Outcomes and Treatment (INGOT) Study
Congdon NG; Krishnadas R; Friedman DS; Goggins W; Ramakrishnan R; Kader MA; Gilbert D; Tielsch J; Quigley HA
Ophthalmic Epidemiology 2012; 19: 149-158 (IGR: 14-2)

49103 Managing Glaucoma in those with Co-morbidity: Not as Easy as it Seems
Roughead EE; Kalisch LM; Pratt NL; Killer G; Barnard A; Gilbert AL
Ophthalmic Epidemiology 2012; 19: 74-82 (IGR: 14-1)

48833 Novel therapies for glaucoma: a patent review 2007 - 2011
Carta F; Supuran CT; Scozzafava A
Expert Opinion on Therapeutic Patents 2012; 22: 79-88 (IGR: 14-1)

48909 Recent clinical pearls from clinical trials in glaucoma
Grover DS; Smith O
Current Opinions in Ophthalmology 2012; 23: 127-134 (IGR: 14-1)

48499 Therapeutics of primary open-angle glaucoma in Cotonou: a series of 224 cases
Sounouvou I; Tchabi S; Monteiro S; Yehouessi L; Doutetien C; Bassabi SK
Journal Français d'Ophtalmologie 2012; 35: 100-105 (IGR: 14-1)

48832 Central Corneal Thickness and Corneal Endothelial Morphology with and without Therapy using Commercially Available Antiglaucomatous Drugs
Weber U
Klinische Monatsblätter für Augenheilkunde 2012; 229: 716-723 (IGR: 14-1)

48824 The Influence of Surgical and Medical Interventions upon Optic Disc Structure in Patients with Primary Open Angle Glaucoma
Xiao H; Liu X; Zhong YM; Mao Z
Eye Science 2011; 26: 185-192 (IGR: 14-1)

48970 Glaucoma and glaucoma medications
Turkoski BB
Orthopaedic nursing / National Association of Orthopaedic Nurses 0; 31: 37-41 (IGR: 14-1)

48686 The willingness of patients presenting with advanced glaucoma to participate in a trial comparing primary medical vs primary surgical treatment
Leighton P; Lonsdale AJ; Tildsley J; King AJ
Eye 2012; 26: 300-306 (IGR: 14-1)

47685 New progresses of glaucoma research in China and abroad
Ge J; Huang J-J; Lan W-Z; Sun X-R
Chinese Journal of Ophthalmology 2010; 46: 893-899 (IGR: 13-4)

48266 Corneal sensitivity in patients treated medically for glaucoma or ocular hypertension
Van Went C; Alalwani H; Brasnu E; Pham J; Hamard P; Baudouin C; Labbé A
Journal Français d'Ophtalmologie 2011; 34: 684-690 (IGR: 13-4)

48264 Survey of medical treatment in primary open-angle glaucoma
Tchabi S; Abouki C; Sounouvou I; Yèhouessi L; Doutetien C; Bassabi SK
Journal Français d'Ophtalmologie 2011; 34: 624-628 (IGR: 13-4)

47591 Principles of treatment of early stage glaucoma: surgery vs. Therapy (review of literature)
Kuroedov AV; Brezhnev AI; Aleksandrov AS; Ogorodnikova VI
Voenno-meditsinski? zhurnal 2011; 332: 28-35 (IGR: 13-4)

48344 Attitudes of consultant ophthalmologists in the UK to initial management of glaucoma patients presenting with severe visual field loss: a national survey
Stead R; Azuara-Blanco A; King AJ
Clinical and Experimental Ophthalmology 2011; 39: 858-864 (IGR: 13-4)

46677 Predisease: When does it make sense?
Viera AJ
Epidemiologic Reviews 2011; 33: 122-134 (IGR: 13-3)

46960 Medical treatment of glaucoma: Present and future
Fogagnolo P; Rossetti L
Expert Opinion on Investigational Drugs 2011; 20: 947-959 (IGR: 13-3)

46534 Pharmacotherapy of glaucoma
Pelcic G; Vitezic D; Mrsic-PELCIC J
Farmaceutski Glasnik 2011; 67: 311-327 (IGR: 13-3)

46749 Newer therapeutic vistas for Antiglaucoma medicines
Kaur IP; Singh H; Kakkar S
Critical Reviews in Therapeutic Drug Carrier Systems 2011; 28: 165-202 (IGR: 13-3)

46777 Open angle glaucoma-trends in management
Sood D; Goyal D; Sood NN
Journal International Medical Sciences Academy 2010; 23: 158-163 (IGR: 13-3)

46638 Monocular Trial of Intraocular Pressure-Lowering Medication. A Prospective Study
King AJ; Uppal S; Rotchford AP; Lakshumanan A; Abedin A; Henry E
Ophthalmology 2011; (IGR: 13-3)

46626 Asymmetry of 24-Hour Intraocular Pressure Reduction by Topical Ocular Hypotensive Medications in Fellow Eyes
Liu JHK; Realini T; Weinreb RN
Ophthalmology 2011; 118, 1995-2000 (IGR: 13-3)

46986 Attitudes Of Consultant Ophthalmologists In The Uk To Initial Management Of Glaucoma Patients Presenting With Severe Visual Field Loss: A national survey
Stead R; Azuara-Blanco A; King AJ
Clinical and Experimental Ophthalmology 2011; (IGR: 13-3)

46468 Intraocular pressure: Modulation as treatment for glaucoma
Caprioli J; Varma R
American Journal of Ophthalmology 2011; 152: 340-344 (IGR: 13-3)

45693 The six keys of the monitoring of the glaucoma patient
Detry-Morel M
Bulletin de la Société Belge d'Ophtalmologie 2010; 316: 63-84 (IGR: 13-2)

46253 Gaucoma: What should the general practitioner know?
Labuschagne MJ
South African Family Practice 2010; 52: 493-497 (IGR: 13-2)

46168 Current and emerging medical therapies in the treatment of glaucoma
Bagnis A; Papadia M; Scotto R; Traverso CE
Expert Opinion on Emerging Drugs 2011; 16: 293-307 (IGR: 13-2)

45832 The management of complicated glaucoma
Clement CI; Goldberg I
Indian Journal of Ophthalmology 2011; 59: 141-147 (IGR: 13-2)

46320 Hazards of topical ophthalmic drug administration
Gunaydin B; Cok OY
Trends in Anaesthesia and Critical Care 2011; 1: 31-34 (IGR: 13-2)

45879 Current dilemmas and controversies in allergic contact dermatitis to ophthalmic medications
Novitskaya ES; Dean SJ; Craig JP; Alexandroff AB
Clinics in Dermatology 2011; 29: 295-299 (IGR: 13-2)

45834 Medical management of glaucoma: Principles and practice
Singh K; Shrivastava A
Indian Journal of Ophthalmology 2011; 59: 88-92 (IGR: 13-2)

45983 Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: A prospective, randomized trial
Katz LJ; Steinmann WC; Kabir A; Molineaux J; Wizov SS; Marcellino G
Journal of Glaucoma 2011; (IGR: 13-2)

45689 Comparison of primary medicament therapy effects and primary argon laser trabeculoplasty on regulation of intraocular pressure and stability of perimetry findings in open angle glaucoma
Sreckovic S; Petrovic MJ; Petrovic N; Vukosavljevic M
Vojnosanitetski pregled. Military-medical and pharmaceutical review 2011; 68: 225-230 (IGR: 13-2)

45700 Glaucoma
Quigley HA
Lancet 2011; 377: 1367-1377 (IGR: 13-2)

28219 Targeting glaucoma beyond intraocular pressure
Rautenstrauss B; Mardin C
Expert Review of Ophthalmology 2010; 5: 217-224 (IGR: 13-1)

28205 Pharmacotherapies for glaucoma
Toris CB
Current Molecular Medicine 2010; 10: 824-840 (IGR: 13-1)

27340 Efficacy of medical therapy in the initial management of acute primary angle closure in Asians
Ramli N; Chai SM; Tan GS; Husain R; Hoh S-T; Ho C-L; Aung T
Eye 2010; 24: 1599-1602 (IGR: 12-4)

27511 Contemporary pharmacotherapy of glaucoma
Ruzickova E; Fichtl M; Betkova J; Kalvodova B
Klinicka Farmakologie a Farmacie 2009; 23: 111-114 (IGR: 12-4)

26898 Targeted preventive measures and advanced approaches in personalised treatment of glaucoma neuropathy
Mozaffarieh M; Fraenkl S; Konieczka K; Flammer J
The EPMA Journal 2010; 1-7 (IGR: 12-3)

25660 The impact of common classes of topical antiglaucoma medications on central corneal thickness--own observations
Wierzbowska J; Lagocka A; Siemiatkowska A; Robaszkiewicz J; Stankiewicz A; Sierdzinski J
Klinika Oczna 2009; 111: 12 323-326 (IGR: 12-2)

26170 Glaucoma management during pregnancy
Denis D; Touvron G
Journal Français d'Ophtalmologie 2010; 33: 346-349 (IGR: 12-2)

25888 Considerations in glaucoma therapy: Fixed combinations versus their component medications
Higginbotham EJ
Clinical Ophthalmology 2010; 4: 1-9 (IGR: 12-2)

25691 Comparing anatomical pattern of topical anti-glaucoma medications associated lacrimal obstruction with a control group
Kashkouli MB; Pakdel F; Hashemi M; Ghaempanah MJ; Rezaee R; Kaghaz-Kanani R; Ahadian A
Orbit 2010; 29: 65-69 (IGR: 12-2)

25787 Medical management of glaucoma: An overview
Rathore KS; Nema RK
International Journal of PharmTech Research 2009; 1: 863-869 (IGR: 12-2)

25954 Medical treatment of primary open-angle glaucoma
Sredkova M; Vassileva P
Autonomic and Autacoid Pharmacology 2010; 30: 49-50 (IGR: 12-2)

25649 Pharmacological and environmental factors in primary angle-closure glaucoma
Subak-Sharpe I; Low S; Nolan W; Foster PJ
British Medical Bulletin 2010; 93: 125-143 (IGR: 12-2)

25806 The current treatment of refractory glaucoma
Zhu Q; Hu Z
Chinese Ophthalmic Research 2010; 28: 371-374 (IGR: 12-2)

25718 Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications
Fechtner RD; Godfrey DG; Budenz D; Stewart JA; Stewart WC; Jasek MC
Cornea 2010; 29: 618-621 (IGR: 12-2)

25721 Physicians treatment decisions, patient persistence, and interruptions in the continuous use of prostaglandin therapy in glaucoma
Hahn SR; Kotak S; Tan J; Kim E
Current Medical Research and Opinion 2010; 26: 957-963 (IGR: 12-2)

26227 Consultant clinical decision making in a glaucoma clinic
Murdoch I; Johnston RL
Eye 2010; 24: 1028-1030 (IGR: 12-2)

25627 Delaying Treatment of Ocular Hypertension: The Ocular Hypertension Treatment Study
Kass MA; Gordon MO; Gao F; Heuer DK; Higginbotham EJ; Johnson CA; Keltner JK; Miller JP; Parrish RK; Wilson MR
Archives of Ophthalmology 2010; 128: 276-287 (IGR: 12-1)

25266 The medical and surgical treatment of glaucoma
Dietlein T S; Hermann M M; Jordan J F
Deutsches Arzteblatt 2009; 106: 597-606 (IGR: 12-1)

25564 Research advances of visual impairment and drug treatment of glaucoma
Wen X -X; Tan D -W
International Journal of Ophthalmology 2010; 10: 97-99 (IGR: 12-1)

25482 The effects of antiglaucomatous topical medications on retinal ganglion cell apoptosis
Karakucuk S; Yuce Y; Ulusal H; Oner A; Gumus K; Mirza E; Mujdeci M
Erciyes Tip Dergisi 2009; 31: 310-317 (IGR: 12-1)

24859 Study of the effects of ocular hypotensive drugs on number of neurons in the retinal ganglion layer in a rat experimental glaucoma
Villena A; Diaz F; Vidal L; Moreno M; Garcia-Campos J; Perez de Vargas I
European Journal of Ophthalmology 2009; 19: 963-970 (IGR: 11-4)

24684 Aerobic exercise and intraocular pressure in normotensive and glaucoma patients
Natsis K; Asouhidou I; Nousios G; Chatzibalis T; Vlasis K; Karabatakis V
BMC Ophthalmology 2009; 9: 6 (IGR: 11-4)

24553 Medical glaucoma therapy
Neuburger M; Dietlein TS; Jordan JF
Padiatrische Praxis 2009; 74: 165-176 (IGR: 11-4)

24648 One-day cross sectional study in Glaucoma
Nordmann JP; Baudouin C; Bron A; Denis P; Renard JP; Rouland JF; Sellem E; Estphan M; Kosa M
Value in Health 2009; 12: A458 (IGR: 11-4)

24534 Medical glaucoma therapy
Neuburger M; Dietlein TS; Jordan JF
Internistische Praxis 2009; 49: 661-672 (IGR: 11-4)

24528 Drug therapy for glaucoma
Maatta M; Puska P
Duodecim; laaketieteellinen aikakauskirja 2009; 125: 1657-1663 (IGR: 11-4)

24662 Ocular hypertension--follow up or treatment?
Stefan C; Dumitrica DM; Dragomir L; Cristea I; Sapundgieva A
Oftalmologia 2009; 1990 (IGR: 11-4)

24584 Medical glaucoma therapy
Neuburger M; Dietlein TS; Jordan JF
Gynakologische Praxis 2009; 33: 565-576 (IGR: 11-4)

24598 A network meta-analysis combined direct and indirect comparisons between glaucoma drugs to rank effectiveness in lowering intraocular pressure
van der Valk R; Webers CAB; Lumley T; Hendrikse F; Prins MH; Schouten JSAG
Journal of Clinical Epidemiology 2009; 62: 1279-1283 (IGR: 11-4)

24171 Incorporating corneal pachymetry into the management of glaucoma
Iester M; Mete M; Figus M; Frezzotti P
Journal of Cataract and Refractive Surgery 2009; 35: 1623-1628 (IGR: 11-3)

24371 Management of pseudoexfoliative glaucoma in a tertiary center in Romania
Danielescu C
Oftalmologia 2009; 53: 71-77 (IGR: 11-3)

24463 Efficacy of topic ocular hipotensive agents after posterior capsulotomy
Minello AA; Prata Junior JA; Mello PA
Arquivos Brasileiros de Oftalmologia 2008; 71: 706-710 (IGR: 11-3)

24090 Meta-analysis of medical intervention for normal tension glaucoma
Cheng JW; Cai JP; Wei RL
Ophthalmology 2009; 116: 1243-1249 (IGR: 11-3)

24369 The management of glaucoma patients in Romania: analysis of an evaluation questionnaire
Chiselita D; Apreutesei N
Oftalmologia 2009; 53: 64-70 (IGR: 11-3)

24151 The impact of available anti-glaucoma therapy on the volume and age profile of patients undergoing glaucoma filtration surgery
Keane PA; Khan MI; Saeed A; Stack J; Tormey P; Hayes P; Beatty S
Eye 2009; 23: 1675-1680 (IGR: 11-3)

24372 Toxic effects of antiglaucoma drugs on superficial tissues of the eye
Pozarowska D
International Review of Allergology and Clinical Immunology 2008; 14: 112-114 (IGR: 11-3)

24256 First-year treatment patterns among new initiators of topical prostaglandin analogs
Schmier JK; Covert DW; Robin AL
Current Medical Research and Opinion 2009; 25: 851-858 (IGR: 11-3)

23468 The safety and efficacy of glaucoma medication in the pediatric population
Coppens G; Stalmans I; Zeyen T; Casteels I
Journal of Pediatric Ophthalmology & Strabismus 2009; 46: 12-18 (IGR: 11-2)

23476 Challenges of glaucoma service delivery in Federal Medical Centre, Azare, Nigeria
Olatunji FO; Ibrahim UF; Muhammad N; Msheliza AA; Ibrahim UY; Rano BT; Ali MU
African Journal of Medicine and Medical Science 2008; 37: 355-359 (IGR: 11-2)

23886 For which glaucoma suspects is it appropriate to initiate treatment?
Cheng EM; Giaconi JA; Coleman AL; Lee BL; Weinreb RN; Newberry SJ; Suttorp MJ; Schonlau M; Fingeret M; Gupta N
Ophthalmology 2009; 116: 710-716 (IGR: 11-2)

23442 Primary open-angle glaucoma: Diagnostic approaches and management
Hazin R; Hendrick AM; Kahook MY
Journal of the National Medical Association 2009; 101: 46-50 (IGR: 11-2)

23975 Side effects of glaucoma treatments
Bron A
Journal Français d'Ophtalmologie 2009; 32: 71-78 (IGR: 11-2)

22841 Recent advances in pharmacotherapy of glaucoma
Gupta S; Galpalli N; Agrawal S; Srivastava S; Saxena R
Indian Journal of Pharmacology 2008; 40: 197-208 (IGR: 11-1)

22604 Switching within glaucoma medication class
Law SK
Current Opinions in Ophthalmology 2009; 20: 110-115 (IGR: 11-1)

22849 Economic evaluation of medication, laser trabeculoplasty and filtering surgeries in treating patients with glaucoma in the US
Cantor LB; Katz LJ; Cheng JW; Chen E; Tong KB; Peabody JW
Current Medical Research and Opinion 2008; 24: 2905-2918 (IGR: 11-1)

21861 Medically controlled glaucoma patients show greater increase in intraocular pressure than surgically controlled patients with the water drinking test
Danesh-Meyer HV; Papchenko T; Tan YW; Gamble GD
Ophthalmology 2008; 115: 1566-1570 (IGR: 10-3)

21873 Intraocular pressure response to medication in a clinical setting: The Marshfield Clinic Personalized Medicine Research Project
McCarty CA; Mukesh BN; Kitchner TE; Hubbard WC; Wilke RA; Burmester JK; Patchett RB
Journal of Glaucoma 2008; 17: 372-377 (IGR: 10-3)

21709 Rates of glaucoma medication utilization among persons with primary open-angle glaucoma, 1992 to 2002
Stein JD; Ayyagari P; Sloan FA; Lee PP
Ophthalmology 2008; 115: 1315-1319 (IGR: 10-3)

21470 Treatment of glaucoma patients with insufficient intraocular pressure control: A survey of German ophthalmologists in private practice
Vorwerk C; Thelen U; Buchholz P; Kimmich F
Current Medical Research and Opinion 2008; 24: 1295-1301 (IGR: 10-3)

21158 Current management of glaucoma and the need for complete therapy
McKinnon SJ; Goldberg LD; Peeples P; Walt JG; Bramley TJ
American Journal of Managed Care 2008; 14: S20-S27 (IGR: 10-2)

21159 Managed care and the impact of glaucoma
Reeder CE; Franklin M; Bramley TJ
American Journal of Managed Care 2008; 14: S5-S10 (IGR: 10-2)

20854 Effects of Central Corneal Thickness on the Efficacy of Topical Ocular Hypotensive Medications
Johnson TV; Toris CB; Fan S; Camras CB
Journal of Glaucoma 2008; 17: 89-99 (IGR: 10-1)

20356 Topical glaucoma therapy as a risk factor for nasolacrimal duct obstruction
Seider N; Miller B; Beiran I
American Journal of Ophthalmology 2008; 145: 120-123 (IGR: 10-1)

20698 The effect of ocular hypotensive agents on macula
Ozturk F; Yavas GF; Kusbeci T
Annals of ophthalmology (Skokie, Ill.) 2007; 39: 302-306 (IGR: 10-1)

20337 Effects of antiglaucoma drugs on refractive outcomes in eyes with myopic regression after laser in situ keratomileusis
Kamiya K; Aizawa D; Igarashi A; Komatsu M; Shimizu K
American Journal of Ophthalmology 2008; 145: 233-238 (IGR: 10-1)

20609 Cardiovascular and respiratory considerations with pharmacotherapy of glaucoma and ocular hypertension
Han JA; Frishman WH; Wu Sun S; Palmiero P-M; Petrillo R
Cardiology in Review 2008; 16: 95-108 (IGR: 10-1)

20423 Drug modification of angiogenesis in a rat cornea model
Schwartz S; George J; Ben-Shoshan J; Luboshits G; Avni I; Levkovitch-Verbin H; Ziv H; Rosner M; Barak A
Investigative Ophthalmology and Visual Science 2008; 49: 250-254 (IGR: 10-1)

20680 Medical interventions for primary open angle glaucoma and ocular hypertension.
Vass C; Hirn C; Sycha T; Findl O; Bauer P; Schmetterer L
Cochrane Database of Systematic Reviews 2007; CD003167 (IGR: 10-1)

20811 Systematic internet-based review of complementary and alternative medicine for glaucoma
Gunasekera V; Ernst E; Ezra DG
Ophthalmology 2008; 115: 435-439 (IGR: 10-1)

20331 Treatment carryover impacts on effectiveness of intraocular pressure lowering agents, estimated by a discrete event simulation model
Denis P; Le Pen C; Umuhire D; Berdeaux G
European Journal of Ophthalmology 2008; 18: 44-51 (IGR: 10-1)

20414 Hospital Episode Statistics and changing trends in glaucoma surgery
Fraser SG; Wormald RP
Eye 2008; 22: 3-7 (IGR: 10-1)

20317 A review of glaucoma treatment in Scotland 1994-2004
Macleod SM; Clark R; Forrest J; Bain M; Bateman N; Azuara-Blanco A
Eye 2008; 22: 251-255 (IGR: 10-1)

20545 Ocular surface changes in primary open angle glaucoma with long term topical anti glaucoma medication
Kamath AP; Satyanarayana S; Rodrigues FEA
Medical Journal Armed Forces India 2007; 63: 341-345 (IGR: 10-1)

20682 Laser trabeculoplasty for open angle glaucoma.
Rolim de Moura C; Paranhos Jr A; Wormald R
Cochrane Database of Systematic Reviews 2007; CD003919 (IGR: 10-1)

20341 Cost analysis of glaucoma medications
Rylander NR; Vold SD
American Journal of Ophthalmology 2008; 145: 106-113 (IGR: 10-1)

19834 Effect of anti-glaucoma topical medications on expression of TGF-β and MMP of human Tenons fibroblast
Zhang J-Y; Leng F; Peng S-M
International Journal of Ophthalmology 2007; 7: 1294-1297 (IGR: 9-4)

19691 Ocular side effects of glaucoma treatment agents
Ehongo A; Bremer F
Bulletin de la Société Belge d'Ophtalmologie 2007; 304: 103-110 (IGR: 9-4)

19910 Co-prescribing of topical and systemic β-blockers in patients with glaucoma: a quality use of medicine issue in Australian practice
Goldberg I; Adena MA
Clinical and Experimental Ophthalmology 2007; 35: 700-705 (IGR: 9-4)

19789 Disease management programs for glaucoma: Has the vision become a reality?
Goldberg LD
Disease Management and Health Outcomes 2007; 15: 199-205 (IGR: 9-4)

20035 Is there more to glaucoma treatment than lowering IOP?
Mozaffarieh M; Flammer J
Survey of Ophthalmology 2007; 52: S174-179 (IGR: 9-4)

19672 Criteria for choosing clinically effective glaucoma treatment: A discussion panel consensus
Thygesen J; Burk R; Carassa R; Crichton A; Goni FJ; Menage M; Miglior S; Montgomery D; Nordmann J-P; Roberts T
Current Therapeutic Research - Clinical and Experimental 2007; 68: 127-136 (IGR: 9-4)

19956 Pay more attention to early diagnosis and intervention for patients with primary glaucoma
Zhao JL
Zhonghua Yan Ke Za Zhi 2007; 43: 769-771 (IGR: 9-4)

20079 Persistency rates for prostaglandin and other hypotensive eyedrops: population-based study using pharmacy claims data
Rait JL; Adena MA
Clinical and Experimental Ophthalmology 2007; 35: 602-611 (IGR: 9-4)

19584 Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of Ophthalmology
Dueker DK; Singh K; Lin SC; Fechtner RD; Minckler DS; Samples JR; Schuman JS
Ophthalmology 2007; 114: 1779-1787 (IGR: 9-3)

19489 Changes in medical and surgical treatments of glaucoma between 1997 and 2003 in France
Kenigsberg PA
European Journal of Ophthalmology 2007; 17: 521-527 (IGR: 9-3)

19423 Retrospection and expectation on drug management of glaucoma
Qiu J-H; Liu X-Y; Wu Z-Q
International Journal of Ophthalmology 2007; 7: 754-758 (IGR: 9-3)

19254 Neuro-hormonal regulation of aqueous humor dynamics as the basis of glaucoma pharmacotherapy. Part II - Aqueous humor outflow
Terelak-Borys B; Liberek I
Klinika Oczna 2007; 109: 64-67 (IGR: 9-3)

19252 Neuro-hormonal regulation of aqueous humor dynamics as the basis of glaucoma pharmacotherapy Part I. Aqueous humor secretion
Terelak-Borys B; Liberek I
Klinika Oczna 2007; 109: 60-63 (IGR: 9-3)

19432 Strategies to reduce the progression of glaucoma
Wadhwa SD; Higginbotham EJ
Aging Health 2007; 3: 397-403 (IGR: 9-3)

19587 Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: The Glaucoma Adherence and Persistency Study
Quigley HA; Friedman DS; Hahn SR
Ophthalmology 2007; 114: 1599-1606 (IGR: 9-3)

17507 Primary open angle glaucoma: Morphological bases for the understanding of the pathogenesis and effects of antiglaucomatic substances
Lutjen-Drecoll E; Kruse FE
Ophthalmologe 2007; 104: 167-179 (IGR: 9-2)

17511 Pharmacologic management of glaucoma in childhood
Moore W; Nischal KK
Pediatric Drugs 2007; 9: 71-79 (IGR: 9-2)

17525 Effective pharmacological treatment of glaucoma involves reducing intraocular pressure by selecting the best regimen for each patient
No authors listed
Drugs and Therapy Perspectives 2007; 23: 18-23 (IGR: 9-2)

18090 Comparison of initial intraocular pressure response with topical β-adrenergic antagonists and prostaglandin analogues in African American and white individuals in the Ocular Hypertension Treatment Study
Mansberger SL; Hughes BA; Gordon MO; Spaner SD; Beiser JA; Cioffi GA; Kass MA; Ocular Hypertension Treatment Study Group
Archives of Ophthalmology 2007; 125: 454-459 (IGR: 9-2)

18147 Should Diamox® and pilocarpine continue to be prescribed?
Sirbat D
Journal Français d'Ophtalmologie 2007; 30: 3S72 - 3S74 (IGR: 9-2)

18029 Rates of glaucoma medication utilization among older adults with suspected glaucoma, 1992 to 2002
Stein JD; Sloan FA; Lee PP
American Journal of Ophthalmology 2007; 143: 870-872 (IGR: 9-2)

17187 Effects of glaucoma medications on corneal endothelium, keratocytes, and subbasal nerves among participants in the Ocular Hypertension Treatment Study
Baratz KH; Nau CB; Winter EJ; McLaren JW; Hodge DO; Herman DC; Bourne WM
Cornea 2006; 25: 1046-1052 (IGR: 9-1)

16847 Canadian perspectives in glaucoma management: the role of central corneal thickness
Behki R; Damji KF; Crichton A
Canadian Journal of Ophthalmology 2007; 42: 66-74 (IGR: 9-1)

17058 The influence of intraocular pressure reduction with medication on retinal nerve fiber layer thickness measurements obtained with scanning laser polarimetry in glaucomatous and hypertensive eyes
Avelino RRG; Luis PAH; Medeiros M; Costa VP
Arquivos Brasileiros de Oftalmologia 2006; 69: 655-659 (IGR: 9-1)

16826 The effects of systemic alpha-1 adrenergic antagonists on pupil diameter in rats
Altan-Yaycioglu R; Yaycioglu O; Tufan H; Akova YA; Ozkardes H
Current Eye Research 2007; 32: 217-221 (IGR: 9-1)

17110 Medical therapy of primitive hypertensive glaucoma-therapeutic principles, perspectives
Cucea R
Oftalmologia 2006; 50: 38-43 (IGR: 9-1)

17005 Prevalence and description of treatment with intraocular pressure-lowering topical medications in continental France
Delcourt C; Bron A; Baudouin C; Denis P; Nordmann JP; Renard JP; Rouland JF; Sellem E; Stephan M; Levrat F
Journal Français d'Ophtalmologie 2006; 29: 1098-1106 (IGR: 9-1)

17034 Medical glaucoma therapy
Jordan JF; Dietlein TS; Dinslage S; Krieglstein GK
Medizinische Monatsschrift für Pharmazeuten 2007; 30: 44-53 (IGR: 9-1)

17060 Glaucoma: Current and developing concepts for inflammation, pathogenesis and treatment
Kumarasamy NA; Lam FS; Wang AL; Theoharides TC
European Journal of Inflammation 2006; 4: 129-137 (IGR: 9-1)

16848 A Canadian glaucoma strategy
Leblanc RP
Canadian Journal of Ophthalmology 2007; 42: 60-65 (IGR: 9-1)

17209 Incorporation of clinical practice guidelines for glaucoma into an ophthalmology electronic medical record
Silverstone DE; Paek HM; Kogan Y; Essaihi A; Shiffman RN
AMIA Annual Symposium Proceedings 2005; 1115 (IGR: 9-1)

16906 Glaucoma management in pregnancy: a questionnaire survey
Vaideanu D; Fraser S
Eye 2007; 21: 341-343 (IGR: 9-1)

16976 Role of early trabeculectomy in primary open-angle glaucoma in the developing world
Anand A; Negi S; Khokhar S; Kumar H; Gupta SK; Murthy GV; Sharma TK
Eye 2007; 21: 40-45 (IGR: 9-1)

16778 Cost-effective evaluation of the glaucoma suspect
Doshi A; Singh K
Current Opinions in Ophthalmology 2007; 18: 97-103 (IGR: 9-1)

15248 Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study
Herman DC; Gordon MO; Beiser JA; Chylack LT Jr; Lamping KA; Schein OD; Soltau JB; Kass MA; Ocular Hypertension Treatment Study (OHTS) Group
American Journal of Ophthalmology 2006; 142: 800-810 (IGR: 8-4)

14954 Glaucoma medications: use and safety in the elderly population
Kanner E; Tsai JC
Drugs and Aging 2006; 23: 321-332 (IGR: 8-4)

14657 Current status of medication for glaucoma in a university hospital
Kokuzawa S; Kondo Y; Yamamoto T
Japanese Journal of Clinical Ophthalmology 2006; 60: 1679-1684 (IGR: 8-4)

14445 Improvement in glaucomatous visual field thresholds after reduction of intraocular pressure: Clinical vs. surgical treatment
Magacho L; Queiroz CF; Medeiros M; Lima FE; Magacho B; Avila M
Arquivos Brasileiros de Oftalmologia 2006; 69: 51-55 (IGR: 8-4)

15082 Failure of medical therapy despite normal intraocular pressure
Walland MJ; Carassa RG; Goldberg I; Grehn F; Heuer DK; Khaw PT; Thomas R; Parikh R
Clinical and Experimental Ophthalmology 2006; 34: 827-836 (IGR: 8-4)

15284 Changes in glaucoma treatment and achieved IOP after introduction of new glaucoma medication
van der Valk R; Schouten JS; Webers CA; Hendrikse F; Prins MH
Graefe's Archive for Clinical and Experimental Ophthalmology 2006; 244: 1267-1272 (IGR: 8-4)

14950 Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost
Covert D; Robin AL
Current Medical Research and Opinion 2006; 22: 971-976 (IGR: 8-4)

15014 Relationship between compliance and background factors of glaucoma patients
Ikushima T; Mori K; Ishibashi T; Ikeda Y; Naruse S; Hozono Y; Kinoshita S
Nippon Ganka Gakkai Zasshi 2006; 110: 497-503 (IGR: 8-4)

15218 Effect of medical therapy on glaucoma filtration surgery rates in Ontario
Rachmiel R; Trope GE; Chipman ML; Gouws P; Buys YM
Archives of Ophthalmology 2006; 124: 1472-1477 (IGR: 8-4)

14060 Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma
Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E
Investigative Ophthalmology and Visual Science 2006; 47: 2917-2923 (IGR: 8-3)

14227 Trabecular meshwork as a new target for the treatment of glaucoma
Ferrer E
Drug News and Perspectives 2006; 19: 151-158 (IGR: 8-3)

14228 Treating ocular hypertension to reduce glaucoma risk: When to treat?
Higginbotham EJ
Drugs 2006; 66: 1033-1039 (IGR: 8-3)

13969 Effects of topical antiglaucoma application on conjunctival impression cytology specimens
Hong S; Lee CS; Seo KY; Seong GJ; Hong YJ
American Journal of Ophthalmology 2006; 142: 185-186 (IGR: 8-3)

14079 Management of ocular hypertension and chronic open-angle glaucoma by French ophthalmologists: the role of target intraocular pressure
Laplace O; Bron A; Nordmann JP
Journal Français d'Ophtalmologie 2006; 29: 353-358 (IGR: 8-3)

13984 The epidemiology of medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994 to 2003
Owen CG; Carey IM; De Wilde S; Whincup PH; Wormald R; Cook DG
British Journal of Ophthalmology 2006; 90: 861-868 (IGR: 8-3)

14078 The French glaucoma and ocular hypertension 1-day study
Villain M; Nordmann JP; Renard JP; Bron A; Delcourt C; Pinchinat S; Solesse De Gendre A; Pelen F
Journal Français d'Ophtalmologie 2006; 29: 520-525 (IGR: 8-3)

14321 The management of glaucoma and intraocular hypertension: Current approaches and recent advances
Noecker RJ
Therapeutics and Clinical Risk Management 2006; 2: 193-206 (IGR: 8-3)

13881 Agreement between optometrists and ophthalmologists on clinical management decisions for patients with glaucoma
Banes MJ; Culham LE; Bunce C; Xing W; Viswanathan A; Garway-Heath D
British Journal of Ophthalmology 2006; 90: 579-585 (IGR: 8-2)

13882 Glaucoma prescribing trends in Australia and New Zealand
Carroll SC; Gaskin BJ; Goldberg I; Danesh-Meyer HV
Clinical and Experimental Ophthalmology 2006; 34: 213-218 (IGR: 8-2)

13883 Glaucoma management trends in Australia and New Zealand
Gaskin BJ; Carroll SC; Gamble G; Goldberg I; Danesh-Meyer HV
Clinical and Experimental Ophthalmology 2006; 34: 208-212 (IGR: 8-2)

13618 Current status of topical medication by glaucoma patients
Kobayashi H; Iwakiri R; Kobayashi K; Okinami S
Japanese Journal of Clinical Ophthalmology 2006; 60: 43-47 (IGR: 8-2)

13617 Patients' awareness of topical medication for glaucoma
Kobayashi H; Iwakiri R; Kobayashi K; Okinami S
Japanese Journal of Clinical Ophthalmology 2006; 60: 37-41 (IGR: 8-2)

13885 24-hour intraocular pressure control with maximum medical therapy compared with surgery in patients with advanced open-angle glaucoma
Konstas AG; Topouzis F; Leliopoulou O; Pappas T; Georgiadis N; Jenkins JN; Stewart WC
Ophthalmology 2006; 113: 765e1 (IGR: 8-2)

13886 Effects of antiglaucoma drugs on collagen gel contraction mediated by human corneal fibroblasts
Liu Y; Yanai R; Lu Y; Hirano S; Sagara T; Nishida T
Journal of Glaucoma 2006; 15: 255-259 (IGR: 8-2)

13681 Effects of antiglaucoma drugs on cellular proliferation in cultured human corneal keratocytes
Wu K-Y; Wang H-Z; Hong S-J
The Kaohsiung Journal of Medical Sciences 2006; 22: 120-125 (IGR: 8-2)

13629 Effects of antiglaucoma drugs on calcium mobility in cultured corneal endothelial cells
Wu K-Y; Hong S-J; Wang H-Z
Kaohsiung Journal of Medical Sciences 2006; 22: 60-67 (IGR: 8-2)

13513 Observational survey on the use of dual therapy in ocular hypertension or glaucoma treatment
Bron A; Nordmann JP; Rouland JF; Baudouin C; Sartral M
Journal Français d'Ophtalmologie 2006; 29: 164-168 (IGR: 8-1)

13348 Systemic reactions associated with ophthalmic medications
Lama PJ
Ophthalmology Clinics of North America 2005; 18: 569-584 (IGR: 8-1)

13511 Activation of TH1/TH2 pathways detected through the expression of CCR4 and CCR5 on the ocular surface of glaucomatous patients treated over the long term
Liang H; Baudouin C; Hamard P; Creuzot-Garcher C; Warnet JM; Brignole-Baudouin F
Journal Français d'Ophtalmologie 2006; 29: 121-126 (IGR: 8-1)

13482 The European Glaucoma Prevention Study and the Ocular Hypertension Treatment Study: why do two studies have different results?
Parrish RK 2nd
Current Opinions in Ophthalmology 2006; 17: 138-141 (IGR: 8-1)

13135 Glaucoma management among individuals enrolled in a single comprehensive insurance plan
Friedman DS; Nordstrom B; Mozaffari E; Quigley HA
Ophthalmology 2005; 112: 1500-1504 (IGR: 7-3)

13132 Variations in treatment among adult-onset open-angle glaucoma patients
Friedman DS; Nordstrom B; Mozaffari E; Quigley HA
Ophthalmology 2005; 112: 1494-1499 (IGR: 7-3)

13142 Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization
Law SK; Song BJ; Fang E; Caprioli J
Ophthalmology 2005; 112: 2123-2130 (IGR: 7-3)

12587 Medical therapy of pediatric glaucoma and glaucoma in pregnancy
Maris PJ Jr; Mandal AK; Netland PA
Ophthalmology Clinics of North America 2005; 18: 461-468 (IGR: 7-3)

13087 A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma
Nagar M; Ogunyomade A; O'Brart DP; Howes F; Marshall J
British Journal of Ophthalmology 2005; 89: 1413-1417 (IGR: 7-3)

13212 Clinical outcomes of glaucoma treatments over a patient lifetime: a Markov model
Nordmann JP; Lafuma A; Deschaseaux C; Berdeaux G
Journal of Glaucoma 2005; 14: 463-469 (IGR: 7-3)

13045 Racial differences in glaucoma care: the longitudinal pattern of care
Ostermann J; Sloan FA; Herndon L; Lee PP
Archives of Ophthalmology 2005; 123: 1693-1698 (IGR: 7-3)

13000 Naturalistic, prospective study of glaucoma and ocular hypertension treatment in France: Strategies, clinical outcomes, and costs at 2 years
Rouland JF; Le Pen C; Benhaddi H; Piriou E; Lilliu H; Kenigsberg PA; Glaucoma Study Group
European Journal of Ophthalmology 2005; 15: 562-580 (IGR: 7-3)

12588 Medical therapy of glaucoma
Singh A
Ophthalmology Clinics of North America 2005; 18: 397-408 (IGR: 7-3)

12585 New ideas for medical therapy of glaucoma in the future
Zou YH; Chiou GCY
International Journal of Ophthalmology 2005; 5: 411-422 (IGR: 7-3)

13048 Selective laser trabeculoplasty as a replacement for medical therapy in open-angle glaucoma
Francis BA; Ianchulev T; Schofield JK; Minckler DS
American Journal of Ophthalmology 2005; 140: 524-525 (IGR: 7-3)

12160 Medical versus surgical interventions for open angle glaucoma
Burr J; Azuara Blanco A; Avenell A
Cochrane Database of Systematic Reviews 2005; 2: CD004399 (IGR: 7-2)

12229 Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials
Maier PC; Funk J; Schwarzer G; Antes G; Falck Ytter YT
British Medical Journal (Clinical Research Edition) 2005; 331: 134 (IGR: 7-2)

12420 Intraocular pressure variability in patients who reached target intraocular pressure
Malerbi FK; Hatanaka M; Vessani RM; Susanna R Jr
British Journal of Ophthalmology 2005; 89: 540-542 (IGR: 7-2)

12231 Management of glaucoma: focus on pharmacological therapy
Marquis RE; Whitson JT
Drugs and Aging 2005; 22: 1-21 (IGR: 7-2)

12428 Lessons for glaucoma from other neurodegenerative diseases: can one treatment suit them all?
Schwartz M
Journal of Glaucoma 2005; 14: 321-323 (IGR: 7-2)

12437 The impact of a nationwide introduction of new drugs and a treatment protocol for glaucoma on the number of glaucoma surgeries
van der Valk R; Schouten JS; Webers CA; Beckers HJ; van Amelsvoort LG; Schouten HJ; Hendrikse F; Prins MH
Journal of Glaucoma 2005; 14: 239-242 (IGR: 7-2)

12468 Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials
van der Valk R; Webers CA; Schouten JS; Zeegers MP; Hendrikse F; Prins MH
Ophthalmology 2005; 112: 1177-85 (IGR: 7-2)

12301 Water-drinking test in patients with primary open-angle glaucoma while treated with different topical medications
Vetrugno M; Sisto D; Trabucco T; Balducci F; Delle Noci N; Sborgia C
Journal of Ocular Pharmacology and Therapeutics 2005; 21: 250-257 (IGR: 7-2)

11927 Acute effects of glaucoma medications on rat intraocular pressure
Pang IH; Wang WH; Clark AF
Experimental Eye Research 2005; 80: 207-214 (IGR: 7-1)

11885 Results of the European Glaucoma Prevention Study
Miglior S; Zeyen T; Pfeiffer N; Cunha-Vaz J; Torri V; Adamsons I; European Glaucoma Prevention Study (EGPS) Group
Ophthalmology 2005; 112: 366-375 (IGR: 7-1)

11676 Suggested formula for setting target intraocular pressure
Aquino MV
Asian Journal of Ophthalmology 2004; 6: 2-6 (IGR: 7-1)

11697 Prospective survey of adverse reactions to topical antiglaucoma medications in a hospital population
Bhatt R; Whittaker KW; Appaswamy S; Desai A; Fitt A; Sandramouli S
Eye 2005; 19: 392-395 (IGR: 7-1)

11725 Glaucoma medication and aqueous humor dynamics
Crowston JG; Weinreb RN
Current Opinions in Ophthalmology 2005; 16: 94-100 (IGR: 7-1)

11815 Preferences for eye drop characteristics among glaucoma specialists: a willingness-to-pay analysis
Jampel HD; Parekh P; Johnson E; Robin AL; Miller RB
Journal of Glaucoma 2005; 14: 151-156 (IGR: 7-1)

11828 The effect of combination pharmacotherapy on the prescription trends of glaucoma medications
Kaiserman I; Kaiserman N; Nakar S; Vinker S
Journal of Glaucoma 2005; 14: 157-160 (IGR: 7-1)

12093 Gold standard medical therapy for glaucoma: defining the criteria identifying measures for an evidence-based analysis
Obstbaum SA; Cioffi GA; Krieglstein GK; Fennerty MB; Alm A; Araie M; Carassa RG; Greve EL; Hitchings RA; Kaufman PL
Clinical Therapeutics 2004; 26: 2102-2120 (IGR: 7-1)

11943 Symmetry of fellow-eye intraocular pressure responses to topical glaucoma medications
Realini T; Vickers WR
Ophthalmology 2005; 112: 599-602 (IGR: 7-1)

11966 The medical management of glaucoma: What we have learned from clinical research trials to aid us in choosing first-line therapy
Schacknow PN
Clinical and Surgical Ophthalmology 2003; 21: 448-454 (IGR: 7-1)

12033 Medication use and retinal vessel diameters
Wong TY; Knudtson MD; Klein BE; Klein R; Hubbard LD
American Journal of Ophthalmology 2005; 139: 373-375 (IGR: 7-1)

12041 New therapies for glaucoma: Are they all up to the task?
Yorio T; Dibas A
Expert Opinion on Therapeutic Patents 2004; 14: 1743-1762 (IGR: 7-1)

11310 Patient expectations for medical and surgical care: a review of the literature and applications to ophthalmology
Dawn AG; Lee PP
Survey of Ophthalmology 2004; 49: 513-524 (IGR: 6-3)

11253 Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study
Brandt JD; Beiser JA; Gordon MO; Kass MA; Ocular Hypertension Treatment Study Group
American Journal of Ophthalmology 2004; 138: 717-722 (IGR: 6-3)

11254 Clinical significance of central corneal thickness in the management ofglaucoma
Shih CY; Graff Zivin JS; Trokel SL; Tsai JC
Archives of Ophthalmology 2004; 122: 1270-1275 (IGR: 6-3)

11437 Applying an evidence-based approach to the management of patients with ocularhypertension: evaluating and synthesizing published evidence
Coleman AL; Singh K; Wilson R; Cioffi GA; Friedman DS; Weinreb RN
American Journal of Ophthalmology 2004; 138: S3-10 (IGR: 6-3)

11484 Effect of ocular hypotensive medications in preventing the progression of visual field damage in patients with normal-tension glaucoma
Nakagami T; Yamazaki Y; Hayamizu F; Tanaka C
Nippon Ganka Gakkai Zasshi 2004; 108: 408-414 (IGR: 6-3)

11482 Structural and immunohistochemical changes of conjunctiva induced by topical glaucoma medication
Nenciu A; Stefan C; Ardelean C
Oftalmologia 2004; 48: 35-42 (IGR: 6-3)

11309 Reducing intraocular pressure: is surgery better than drugs?
Shaarawy T; Flammer J; Haefliger IO
Eye 2004; 18: 1215-1224 (IGR: 6-3)

11552 Clinical course of glaucoma over two years. Comparison of medically and surgically treated eyes
Tokuda N; Inoue J; Aoyama Y
Japanese Journal of Clinical Ophthalmology 2004; 58: 1645-1649 (IGR: 6-3)

11293 Glaucoma treatment in Australia: changing patterns of therapy 1994-2003
Walland MJ
Clinical and Experimental Ophthalmology 2004; 32: 590-596 (IGR: 6-3)

11492 Persistency and treatment failure in newly diagnosed open angle glaucoma patients in the United Kingdom
Zhou Z; Althin R; Sforzolini BS; Dhawan R
British Journal of Ophthalmology 2004; 88: 1391-1394 (IGR: 6-3)

10571 The circadian effects of antiglaucomatous drugs
Bron A
Journal Français d'Ophtalmologie 2004; 27, Hors série 2: 2S33-2S38 (IGR: 6-2)

10609 How prostaglandins have changed the medical approach to glaucoma and its costs: an observational study of 2228 patients treated with glaucoma medications
De Natale R; Draghi E; Dorigo MT
Acta Ophthalmologica Scandinavica 2004; 82: 393-6 (IGR: 6-2)

10614 Circadian rhythm variations of intraocular pressure and therapeutic decisions: interpretation of clinical trial results based on a statistical model
Denis P; Berdeaux G
Journal Français d'Ophtalmologie 2004; 27, Hors série 2: 2S39-2S43 (IGR: 6-2)

10613 Medical outcomes of glaucoma therapy from a nationwide representative survey
Denis P; Lafuma A; Berdeaux G
Clinical Drug Investigation 2004; 24: 343-352 (IGR: 6-2)

10671 The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals
Higginbotham EJ; Gordon MO; Beiser JA; Drake MV; Bennett GR; Wilson MR; Kass MA; Ocular Hypertension Treatment Study Group
Archives of Ophthalmology 2004; 122: 813-20 (IGR: 6-2)

10673 Inhibitory effects of anti-glaucoma drugs on corneal epithelial migration in a rabbit organ culture system
Hirano S; Sagara T; Suzuki K; Seki K; Nishida T
Journal of Glaucoma 2004; 13: 196-9 (IGR: 6-2)

10708 Antiglaucoma eye drop pulses--increased interleukin-6 secretion by Tenon's capsule fibroblast cultures
Koh SW; Coll TJ; Rose L; Matsumoto Y; Higginbotham EJ
Journal of Glaucoma 2004; 13: 200-9 (IGR: 6-2)

10789 Corneal and conjunctival changes caused by commonly used glaucoma medications
Noecker RJ; Herrygers LA; Anwaruddin R
Cornea 2004; 23: 490-496 (IGR: 6-2)

10915 Inhibition of endothelin-1 and KC1-induced increase of [Ca ²⁺]_i by antiglaucoma drugs in cultured A7r5 vascular smooth-muscle cells
Wu K-Y; Wang H-Z; Hong S-J
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 201-209 (IGR: 6-2)

10100 Resistance training exercises acutely reduce intraocular pressure in physically active men and women
Chromiak JA; Abadie BR; Braswell RA; Koh YS; Chilek DR
Journal of Strength and Condition Research 2003; 17: 715-720 (IGR: 6-1)

10098 The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results
Ederer F; Gaasterland DA; Dally LG; Kim J; VanVeldhuisen PC; Blackwell B; Prum B; Shafranov G; Allen RC; Beck A
Ophthalmology 2004; 111: 651-664 (IGR: 6-1)

10097 Is addition of a third or fourth antiglaucoma medication effective?
Neelakantan A; Vaishnav HD; Iyer SA; Sherwood MB
Journal of Glaucoma 2004; 13: 130-136 (IGR: 6-1)

10099 The uniocular drug trial and second-eye response to glaucoma medications
Realini T; Fechtner RD; Atreides SP; Gollance S
Ophthalmology 2004; 111: 421-426 (IGR: 6-1)

10104 Patient persistency with topical ocular hypotensive therapy in a managed care population
Reardon G; Schwartz GF; Mozaffari E
American Journal of Ophthalmology 2004; 137: S3-12 (IGR: 6-1)

10103 Persistency with latanoprost or timolol in primary open-angle glaucoma suspects
Schwartz GF; Reardon G; Mozaffari E
American Journal of Ophthalmology 2004; 137: S13-16 (IGR: 6-1)

10093 Fixed combinations of topical glaucoma medications
Fechtner RD; Realini T
Current Opinions in Ophthalmology 2004; 15: 132-135 (IGR: 6-1)

10096 Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial
Leske MC; Heijl A; Hyman L; Bengtsson B; Komaroff E
Current Opinions in Ophthalmology 2004; 15: 102-106 (IGR: 6-1)

10095 Current management of glaucoma
Schwartz K; Budenz D
Current Opinions in Ophthalmology 2004; 15: 119-126 (IGR: 6-1)

10094 Glaucoma management in developing countries: medical, laser, and surgical options for glaucoma management in countries with limited resources
Thomas R; Sekhar GC; Kumar RS
Current Opinions in Ophthalmology 2004; 15: 127-131 (IGR: 6-1)

9665 In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells
Hamard P; Blondin C; Debbasch C; Warnet JM; Baudouin C; Brignole F
Graefe's Archive for Clinical and Experimental Ophthalmology 2003; 241: 1037-1043 (IGR: 5-3)

9878 Glaucoma and ocular hypertension: the importance of intraocular pressure in treatment decisions in France
Bron A; Nordmann JP; Baudouin C; Rouland JF; Kadi A; Sartral M
Journal Français d'Ophtalmologie 2003; 26: 895-903 (IGR: 5-3)

9882 Prescription of topical antiglaucoma agents for patients with contraindications to beta-blockers
Houde M; Castilloux AM; Tingey D; Assalian A; LeLorier J
Canadian Journal of Ophthalmology 2003; 38: 469-475 (IGR: 5-3)

10036 How to conduct glaucoma therapy when pressure stays high despite topical treatment?
Nordmann JP
Journal Français d'Ophtalmologie 2003; 26, Hors série 2: 2S53-2S55 (IGR: 5-3)

9880 Compliance barriers in glaucoma: a systematic classification
Tsai JC; McClure CA; Ramos SE; Schlundt DG; Pichert JW
Journal of Glaucoma 2003; 12: 393-398 (IGR: 5-3)

9879 Compliance of medical treatment in primitive glaucoma open angle
Wane AM; Ndiaye MR; Wade A; Ndiaye PA; Ba EA; De Medeiros ME; Ndoye PA; Ndiaye CS; Kameni A
Journal Français d'Ophtalmologie 2003; 26: 1039-1044 (IGR: 5-3)

8928 Collaborative normal tension glaucoma study
Anderson DR
Current Opinions in Ophthalmology 2003; 14: 86-90 (IGR: 5-2)

8925 Changes in medical and surgical treatments of glaucoma between 1997 and 2000 in France
Baudouin C; Rouland JF; Le Pen C
European Journal of Ophthalmology 2003; 13 (Suppl 4): S53-S60 (IGR: 5-2)

8929 Review of recent publications of the advanced glaucoma intervention study
Beck AD
Current Opinions in Ophthalmology 2003; 14: 83-85 (IGR: 5-2)

8926 Initial management of ocular hypertension and primary open-angle glaucoma: an evaluation of the Royal College of Ophthalmologists' Guidelines
Choong YF; Devarajan N; Pickering A; Pickering S; Austin MW
Eye 2003; 7: 685-690 (IGR: 5-2)

8927 Collaborative initial Glaucoma Treatment Study: a summary of results to date
Feiner L; Piltz Seymour JR
Current Opinions in Ophthalmology 2003; 14: 106-111 (IGR: 5-2)

8930 Ocular Hypertension Treatment Study (OHTS) commentary
Lee BL; Wilson MR
Current Opinions in Ophthalmology 2003; 14: 74-77 (IGR: 5-2)

8924 Glaucoma clinical trials and what they mean for our patients
Lichter PR
American Journal of Ophthalmology 2003; 136: 136-145 (IGR: 5-2)

8931 Multifunctional drugs for endothelial dysfunction in diabetes and glaucoma
Wood PL
Idrugs 2003; 6: 360-367 (IGR: 5-2)

8425 Intraocular pressure fluctuations in medical versus surgically treated glaucomatous patients
Medeiros FA; Pinheiro A; Moura FC; Leal BC; Susanna R Jr
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 489-498 (IGR: 5-1)

8666 Medical management of angle closure glaucoma
Hoh ST; Aung T; Chew PTK
Seminars in Ophthalmology 2002; 17: 79-83 (IGR: 5-1)

8807 Best practice treatment algorithm for primary open-angle glaucoma: implications for U.S. ophthalmology practice
Serle J; Cantor LB; Gross R; Katz J; Mundorf T; Noecker RS; Severin T; Simmons S; Walt J; Casciano J
American Journal of Ophthalmology 2003; 135: 264 (IGR: 5-1)

8833 Evidence-based medicine: The Finnish evidence-based guideline for openangle glaucoma
Tuulonen A; Airaksinen PJ; Erola E; Forsman E; FribergK; Kaila M; Klemetti A; Mäkelä M; Oskala P; Puska P
Acta Ophthalmologica Scandinavica 2003; 81: 3-18 (IGR: 5-1)

8124 The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma
The AGIS Investigators
American Journal of Ophthalmology 2002; 134: 499-512 (IGR: 4-3)

8094 A point of contact between clinics and researches in glaucoma
Abe H
Neuro-Ophthalmology Japan 2002; 19: 71-76 (IGR: 4-3)

8096 Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data
Dasgupta S; Oates V; Bookhart BK; Vaziri B; Schwartz GF; Mozaffari E
American Journal of Management Care 2002; 8: S255-261 (IGR: 4-3)

8093 Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial
Heijl A; Leske MC; Bengtsson B; Hyman L; Hussein M
Archives of Ophthalmology 2002; 120: 1268-1279 (IGR: 4-3)

8092 Target intraocular pressure and risk factors for progression of visual field loss in primary open-angle glaucoma
Ogawa T; Ogawa A; So K
Nippon Ganka Gakkai Zasshi 2002; 106: 488-493 (IGR: 4-3)

8095 Measuring persistency and intraocular pressure-controlled days in patients receiving topical glaucoma medications
Schwartz GF; Platt R
American Journal of Management Care 2002; 8: S278-280 (IGR: 4-3)

8097 Discontinuation rates of topical glaucoma medications in a managed care population
Shaya FT; Mullins CD; Wong W; Cho J
American Journal of Management Care 2002; 8: S271-277 (IGR: 4-3)

8091 Rates of discontinuation and change of glaucoma therapy in a managed care setting
Spooner JJ; Bullano MF; Ikeda LI; Cockerham TR; Waugh WJ; Johnson T; Mozaffari E
American Journal of Management Care 2002; 8: S262-270 (IGR: 4-3)

8296 Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study
Taylor SA; Galbraith SM; Mills RP
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 401-409 (IGR: 4-3)

3461 Frequency of asymmetric intraocular pressure fluctuations among patients with and without glaucoma
Realini T; Barber L; Burton D
Ophthalmology 2002; 109: 1367-1371 (IGR: 4-2)

3559 The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care
Bateman DN; Clark R; Azuara Blanco A; Bain M; Forrest J
British Journal of Ophthalmology 2002; 86: 551-554 (IGR: 4-2)

3560 Ocular hypertension and glaucoma: the contribution of large studies to daily practice
Bron A
Journal Français d'Ophtalmologie 2002; 25: 641-54 (IGR: 4-2)

3704 Best practice treatment algorithm for primary open-angle glaucoma: implications for US ophthalmology practice
Serle J; Cantor L; Gross R; Katz J; Mundorf T; Noecker R; Severin T; Simmons S; Walt J; Casciano J
Managed Care Interface 2002; 15: 37-48 (IGR: 4-2)

3562 Duration of therapy provided by bottle of ocular hypotensive eyedrops
Vaidergorn PG; Susanna Jr R; Borges AS; Giampani Jr J
Revista Brasileira de Oftalmologia 2002; 61: 278-282 (IGR: 4-2)

3563 Emerging perspectives in glaucoma: optimizing 24-hour control of intraocular pressure
Wax MB; Camras CB; Fiscella RG; Girkin C; Singh K; Weinreb RN
American Journal of Ophthalmology 2002; 133: S1-10 (IGR: 4-2)

3564 Clinical evaluation of the effectiveness of the combined use of local and general hypotensive agents in patients with glaucoma and hypertension
Zakharova IA; Makhmutov VI; Pristavka VA; Kul'kova SV
Vestnik Oftalmologii 2002; 118: 44-46 (IGR: 4-2)

6818 Ocular surface problems following topical medication
Bernauer W
Klinische Monatsblätter für Augenheilkunde 2002; 219: 240-142 (IGR: 4-1)

6819 Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on beta-adrenergic blockade
Frishman WH; Kowalski M; Nagnur S; Warshafsky S; Sica D
Heart Disease 2001; 3: 386-397 (IGR: 4-1)

6820 Primary drug treatment for glaucoma: beta-blockers versus other medications
Stamper RL; Wigginton SA; Higginbotham EJ
Survey of Ophthalmology 2002; 47: 63-73 (IGR: 4-1)

6821 Advances in topical glaucoma therapy
Willis AM; Diehl KA; Robbin TE
Veterinary Ophthalmology 2002; 5: 9-17 (IGR: 4-1)

18386 Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery
Lichter PR; Musch DC; Gillespie BW; Guire KE; Janz NK; Wren PA; Mills RP; CIGTS Study Group
Ophthalmology 2001; 108: 1943-1953 (IGR: 3-3)

18385 When to begin glaucoma treatment?
Nordmann JP
Journal Français d'Ophtalmologie 2001; 24: 1092-1094 (IGR: 3-3)

18384 New medical treatment in glaucoma: new strategies?
Renard JP; May F; Rigal-Sastourne JC; Maurin JF
Journal Français d'Ophtalmologie 2001; 24: 1095-1099 (IGR: 3-3)

18383 Iatrogenic limbal stem cell deficiency: when glaucoma management contributes to corneal disease
Schwartz GS; Holland EJ
Journal of Glaucoma 2001; 10: 443-445 (IGR: 3-3)

6357 Medical and surgical management of the glaucoma patient
Abrams KL
Clinical Techniques in Small Animal Practice 2001; 16: 71-76 (IGR: 3-2)

6362 Ocular pharmacology
Champagne ES
Clinical Techniques in Small Animal Practice 2001; 16: 13-16 (IGR: 3-2)

6418 An observational, retrospective two-year cost study in primary open-angle glaucoma and ocular hypertension in newly diagnosed patients
Rouland JF; Peigne G; Sellem E; Renard JP; Williamson W; Filippi JM; Cohn H; Hamard P; Abellan P; Chagnon A
Journal Français d'Ophtalmologie 2001; 24: 233-243 (IGR: 3-2)

6457 Range of topically active medications for treatment of glaucoma may reduce the need for surgery
Authors unknown
Drugs and Therapy Perspectives 2001; 17: 5-10 (IGR: 3-2)

6458 Glaucoma care in West Africa
Budenz DL; Sing K
Journal of Glaucoma 2001; 10: 348-353 (IGR: 3-2)

19094 Consumption of glaucoma medication
Calissendorff BM
Acta Ophthalmologica Scandinavica 2001; 79: 2-5 (IGR: 3-1)

19095 Management and prognosis of end-stage glaucoma
Gillies WE; Brooks AMV; Strang NT
Clinical and Experimental Ophthalmology 2000; 28: 405-408 (IGR: 3-1)

19096 Natural therapies for ocular disorders part two: cataracts and glaucoma
Head KA
Alternative Medicine Review 2001; 6: 141-166 (IGR: 3-1)

19097 Management of glaucoma in pregnancy and lactation
Johnson SM; Martinez M; Freedman S
Survey of Ophthalmology 2001; 45: 449-454 (IGR: 3-1)

19098 An observational, retrospective, two-year cost study in primary open-angle glaucoma and ocular hypertension in newly diagnosed patients
Rouland J-F; Peigne G; Sellem E; Renard J-P; Williamson W; Filippi J-M; Cohn H; Hamard P; Abellan P; Chagnon A
Journal Français d'Ophtalmologie 2001; 24: 233-243 (IGR: 3-1)

19099 The birth of ocular pharmacology in the 20th century
Williams PB; Crouch ER Jr; Sheppard JD Jr; Lattanzio FA Jr; Parker TA; Mitrev PV
Journal of Clinical Pharmacology 2000; 40: 990-1006 (IGR: 3-1)

15684 The efficacy of topical prophylactic antiglaucoma therapy in primary closed angle glaucoma in dogs: a multicenter clinical trial
Miller PE; Schmidt GM; Vainisi SJ; Swanson JF; Herrmann MK
Journal of the American Animal Hospital Association 2000; 36: 431-438 (IGR: 2-3)

15902 Bioavailability of antiglaucoma drugs
Demailly P
Journal Français d'Ophtalmologie 2000; 23: 518-522,523 (IGR: 2-3)

15824 Compliance and viewpoint of glaucoma patients in Greece
Konstas AG; Maskaleris G; Gratsonidis S; Sardelli C
Eye 2000; 14: 752-756 (IGR: 2-3)

15851 Emerging perspectives on glaucoma: highlights of a round table discussion
Lee DA
American Journal of Ophthalmology 2000; 130: 1-11 (IGR: 2-3)

15964 Target intraocular pressure in glaucoma management
Realini T; Fechtner RD
Ophthalmology Clinics of North America 2000; 13: 407-415 (IGR: 2-3)

15658 Directed therapy for specific glaucomas
Ritch R
Ophthalmology Clinics of North America 2000; 13: 429-441 (IGR: 2-3)

15953 Choosing initial and combination medical therapy for glaucoma
Wigginton SA; Higginbotham EJ
Ophthalmology Clinics of North America 2000; 13: 417-427 (IGR: 2-3)

5972 The evaluation of morphological status of bulbar conjunctiva after long-term antiglaucoma drug therapy
Pozarowska D; Toczolowski J; Wozniak F
Klinika Oczna 1999; 455-458 (IGR: 2-2)

6163 Adverse effects of topical antiglaucoma drugs on the ocular surface
Arici MK; Arici DS; Topalkara A; Guler C
Clinical and Experimental Ophthalmology 2000; 28: 113-117 (IGR: 2-2)

6164 Glaucoma medical treatment: Philosophy, principles and practice
Migdal C
Eye 2000; 14: 515-518 (IGR: 2-2)

5700 Pharmacotherapy of congenital glaucoma in young children
Koraszewska-Matuszewska B
Klinika Oczna 1999; 101:393-396 (IGR: 2-1)

5773 Which patients are treated for glaucoma? An observational analysis
Bohn RL; Gurwitz JH; Yeomans SM; Glynn RJ; Pasquale LR; Walker AM; Avorn J
Journal of Glaucoma 2000; 9:38-44 (IGR: 2-1)

5774 Does that drug work? Pitfalls in studies on the efficacy and safety of glaucoma medications (editorial)
Camras CB; Minckler D
American Journal of Ophthalmology 2000; 129: 87-89 (IGR: 2-1)

5775 Free radical production in patients undergoing long-term topical antiglaucoma treatment or contact lens wearers by impression cytology specimens
Debbasch C; Pisella P-J; Rat P; Warnet J-M; Baudouin Ch
Journal Français d'Ophtalmologie 2000; 23: 239-244 (IGR: 2-1)

5776 Initial medical management of open-angle glaucoma
Fechtner RD
Journal of Glaucoma 2000; 9: 83-86 (IGR: 2-1)

5777 Pharmacological therapy for glaucoma: a review
Hoyng PFJ; Van Beek LM
Drugs 2000; 59: 411-434 (IGR: 2-1)

5778 Antiglaucoma medications: a review of safety and tolerability issues related to their use
Schuman JS
Clinical Therapeutics 2000; 22:167-208 (IGR: 2-1)

5779 Target pressure--glaucomatologists' holey grail (editorial)
Singh K; Spaeth G; Zimmerman T; Minckler D
Ophthalmology 2000; 107: 629-30 (IGR: 2-1)

5780 Target pressures in glaucoma
Zeyen T
Bulletin de la Société Belge d'Ophtalmologie 1999; 274:61-65 (IGR: 2-1)

15437 Early Manifest Glaucoma Trial: design and baseline data
Leske MC; Heijl A; Hyman L; Bengtsson B
Ophthalmology 1999; 106: 2144-2153 (IGR: 1-3)

15496 Efficacy and adverse effects of medications used in the treatment of glaucoma
Camras CB; Toris CB; Tamesis RR
Drugs and Aging 1999; 15: 377-388 (IGR: 1-3)

15497 Factors associated with use of glaucoma medications in a population of older people: the Blue Mountains Eye Study
Hourihan F; Mitchell P
Australian and New Zealand Journal of Ophthalmology 1999; 27: 176-179 (IGR: 1-3)

15498 Daily cost of newer glaucoma agents
Stewart WC; Hudgins AC; Pruitt CA; Sine CS
Journal of Ocular Pharmacology and Therapeutics 1999; 15: 379-388 (IGR: 1-3)

5184 Metaplazja plaskonablonkowa spojowki galkoweg w przebiegu dlugotrwalego stosowania lekow przeciwjaskrowych (Squamous metaplasia of bulbar conjunctiva in the course of long-term topical antiglaucoma therapy)
Wroblewska E
Klinika Oczna 1999; 101: 41-43 (IGR: 1-2)

5185 Liczba komorek kubkowych w spojowce galkowej po dlugotrwalym stosowaniu lekow przeciwjaskrowych (Goblet cells density of bulbar conjunctiva after long-term topical antiglaucoma therapy)
Wroblewska E
Klinika Oczna 1999; 101: 45-47 (IGR: 1-2)

5389 The Ocular Hypertension Treatment Study: design and baseline description of the participants.
Gordon MO; Kass MA
Archives of Ophthalmology 1999; 117: 573-583 (IGR: 1-2)

5390 Assessment of ocular hypotensive mechanisms and additivity of antiglaucoma drugs in humans (editorial; comment)
Kaufman PF
Archives of Ophthalmology 1999; 117: 673-674 (IGR: 1-2)

5391 Use of guidelines in the management of patients with glaucoma
Lee P
Disease Management and Health Outcomes 1999; 5: 187-195 (IGR: 1-2)

5392 Glaucoma comanagement: A practical guide
Meckelborg CB
Practical Optometry 1999; 10: 96-100 (IGR: 1-2)

5393 Ethical considerations related to outcome studies-based clinical practice guidelines
Panek WC
Journal of Glaucoma 1999; 8: 267-272 (IGR: 1-2)

5394 Perspectives in the medical treatment of glaucoma
Stewart WC
Current Opinions in Ophthalmology 1999; 10: 99-108 (IGR: 1-2)

5395 Incidence of keratopathy following long-term instillation of single or multiple antiglaucomatous medications
Takahashi N; Hatafuku M; Nishimura T; Hosobe Y; Tazawa Y
Japanese Journal of Clinical Ophthalmology 1999; 53: 1199-1203 (IGR: 1-2)

5396 The role of medical therapy in the rank order of glaucoma treatment
Wilensky JT
Current Opinions in Ophthalmology 1999; 10: 109-111 (IGR: 1-2)

5397 Proba Schirmera I I czas przerwania filmu izowego u chorych stosujacuch przewlekle leki przeciwjaskrowe (Schirmer test I and BUT (break-up time) in patients treated with topical antiglaucoma drugs for a long time)
Wroblewska E
Klinika Oczna 1999; 101: 49-50 (IGR: 1-2)

12.1 General management, indication (523 abstracts found)

94750 Outcomes of Management of Glaucoma in Phacomatosis Pigmentovascularis Over the Last Three Decades: A Single-Center Experience
Mandal AK
Ophthalmology. Glaucoma 2022; 5: 101-109 (IGR: 22-2)

94875 Real-world Surgical Outcomes of Primary Angle-closure Glaucoma
Wanichwecharungruang B
Clinical Ophthalmology 2021; 15: 2823-2833 (IGR: 22-2)

94711 Different surgical modalities for management of uveitic glaucoma: 2 year comparative study
El-Saied HMA
Acta Ophthalmologica 2022; 100: e246-e252 (IGR: 22-2)

94843 Primary congenital glaucoma surgery: outcomes and visual function
Gusson E
International Ophthalmology 2021; 0: (IGR: 22-2)

94318 Microinvasive Glaucoma Surgery in US Ophthalmology Residency: Surgical Case Log Cross-sectional Analysis and Proposal for New Glaucoma Procedure Classification
Qiu M
Journal of Glaucoma 2021; 30: 621-628 (IGR: 22-2)

94696 Trends in Surgical Glaucoma Treatment in Germany Between 2006 and 2018
Luebke J
Clinical epidemiology 2021; 13: 581-592 (IGR: 22-2)

94450 Comparison of Patient-Reported Functional Recovery From Different Types of Ophthalmic Surgery
Bicket AK
American Journal of Ophthalmology 2021; 227: 201-210 (IGR: 22-2)

94843 Primary congenital glaucoma surgery: outcomes and visual function
Chemello F
International Ophthalmology 2021; 0: (IGR: 22-2)

94450 Comparison of Patient-Reported Functional Recovery From Different Types of Ophthalmic Surgery
Mihailovic A
American Journal of Ophthalmology 2021; 227: 201-210 (IGR: 22-2)

94318 Microinvasive Glaucoma Surgery in US Ophthalmology Residency: Surgical Case Log Cross-sectional Analysis and Proposal for New Glaucoma Procedure Classification
Woreta FA
Journal of Glaucoma 2021; 30: 621-628 (IGR: 22-2)

94750 Outcomes of Management of Glaucoma in Phacomatosis Pigmentovascularis Over the Last Three Decades: A Single-Center Experience
Kodavati K
Ophthalmology. Glaucoma 2022; 5: 101-109 (IGR: 22-2)

94875 Real-world Surgical Outcomes of Primary Angle-closure Glaucoma
Phumratprapin C
Clinical Ophthalmology 2021; 15: 2823-2833 (IGR: 22-2)

94711 Different surgical modalities for management of uveitic glaucoma: 2 year comparative study
Abdelhakim MASE
Acta Ophthalmologica 2022; 100: e246-e252 (IGR: 22-2)

94696 Trends in Surgical Glaucoma Treatment in Germany Between 2006 and 2018
Boehringer D
Clinical epidemiology 2021; 13: 581-592 (IGR: 22-2)

94843 Primary congenital glaucoma surgery: outcomes and visual function
Longo R
International Ophthalmology 2021; 0: (IGR: 22-2)

94696 Trends in Surgical Glaucoma Treatment in Germany Between 2006 and 2018
Anton A
Clinical epidemiology 2021; 13: 581-592 (IGR: 22-2)

94318 Microinvasive Glaucoma Surgery in US Ophthalmology Residency: Surgical Case Log Cross-sectional Analysis and Proposal for New Glaucoma Procedure Classification
Boland MV
Journal of Glaucoma 2021; 30: 621-628 (IGR: 22-2)

94750 Outcomes of Management of Glaucoma in Phacomatosis Pigmentovascularis Over the Last Three Decades: A Single-Center Experience
Gothwal VK
Ophthalmology. Glaucoma 2022; 5: 101-109 (IGR: 22-2)

94875 Real-world Surgical Outcomes of Primary Angle-closure Glaucoma
Kongsomboon K
Clinical Ophthalmology 2021; 15: 2823-2833 (IGR: 22-2)

94450 Comparison of Patient-Reported Functional Recovery From Different Types of Ophthalmic Surgery
Zheng C
American Journal of Ophthalmology 2021; 227: 201-210 (IGR: 22-2)

94696 Trends in Surgical Glaucoma Treatment in Germany Between 2006 and 2018
Daniel M
Clinical epidemiology 2021; 13: 581-592 (IGR: 22-2)

94875 Real-world Surgical Outcomes of Primary Angle-closure Glaucoma
Seresirikachorn K
Clinical Ophthalmology 2021; 15: 2823-2833 (IGR: 22-2)

94843 Primary congenital glaucoma surgery: outcomes and visual function
Franzolin E
International Ophthalmology 2021; 0: (IGR: 22-2)

94450 Comparison of Patient-Reported Functional Recovery From Different Types of Ophthalmic Surgery
Kashaf MS
American Journal of Ophthalmology 2021; 227: 201-210 (IGR: 22-2)

94696 Trends in Surgical Glaucoma Treatment in Germany Between 2006 and 2018
Reinhard T
Clinical epidemiology 2021; 13: 581-592 (IGR: 22-2)

94843 Primary congenital glaucoma surgery: outcomes and visual function
Vesentini R
International Ophthalmology 2021; 0: (IGR: 22-2)

94450 Comparison of Patient-Reported Functional Recovery From Different Types of Ophthalmic Surgery
Nagarajan N
American Journal of Ophthalmology 2021; 227: 201-210 (IGR: 22-2)

94696 Trends in Surgical Glaucoma Treatment in Germany Between 2006 and 2018
Lang S
Clinical epidemiology 2021; 13: 581-592 (IGR: 22-2)

94450 Comparison of Patient-Reported Functional Recovery From Different Types of Ophthalmic Surgery
Huang AS
American Journal of Ophthalmology 2021; 227: 201-210 (IGR: 22-2)

94843 Primary congenital glaucoma surgery: outcomes and visual function
Verlato G; Marchini G
International Ophthalmology 2021; 0: (IGR: 22-2)

94450 Comparison of Patient-Reported Functional Recovery From Different Types of Ophthalmic Surgery
Chapagain S; Da J; Ramulu PY
American Journal of Ophthalmology 2021; 227: 201-210 (IGR: 22-2)

92586 The Effects of Glaucoma and Glaucoma Therapies on Corneal Endothelial Cell Density
Realini T
Journal of Glaucoma 2021; 30: 209-218 (IGR: 22-1)

92154 Risk factors leading to trabeculectomy surgery of glaucoma patient using Japanese nationwide administrative claims data: a retrospective non-interventional cohort study
Shirai C
BMC Ophthalmology 2021; 21: 153 (IGR: 22-1)

92438 What Is New in Glaucoma: From Treatment to Biological Perspectives
Nuzzi R
Journal of Ophthalmology 2021; 2021: 5013529 (IGR: 22-1)

92172 The Aging Lens and Glaucoma in persons over 50: Why early cataract surgery/refractive lensectomy and microinvasive trabecular bypass can prevent blindness and cure elevated eye pressure
Laroche D
Journal of the National Medical Association 2021; 113: 471-473 (IGR: 22-1)

92362 What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews
Qureshi R
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)

92540 Surgical and Perioperative Considerations for the Treatment of Cataract in Eyes with Glaucoma: A Literature Review
Tsakiris K
Journal of Ophthalmology 2021; 2021: 5575445 (IGR: 22-1)

92154 Risk factors leading to trabeculectomy surgery of glaucoma patient using Japanese nationwide administrative claims data: a retrospective non-interventional cohort study
Shirai C
BMC Ophthalmology 2021; 21: 153 (IGR: 22-1)

91905 Glaucoma
Kang JM
The Medical clinics of North America 2021; 105: 493-510 (IGR: 22-1)

92418 Changing trends in glaucoma surgery within Australia
Sun MT; Madike R
British Journal of Ophthalmology 2022; 106: 957-961 (IGR: 22-1)

92362 What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews
Azuara-Blanco A
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)

92586 The Effects of Glaucoma and Glaucoma Therapies on Corneal Endothelial Cell Density
Gupta PK
Journal of Glaucoma 2021; 30: 209-218 (IGR: 22-1)

92540 Surgical and Perioperative Considerations for the Treatment of Cataract in Eyes with Glaucoma: A Literature Review
Kontadakis G
Journal of Ophthalmology 2021; 2021: 5575445 (IGR: 22-1)

91905 Glaucoma
Tanna AP
The Medical clinics of North America 2021; 105: 493-510 (IGR: 22-1)

92154 Risk factors leading to trabeculectomy surgery of glaucoma patient using Japanese nationwide administrative claims data: a retrospective non-interventional cohort study
Tsuda S
BMC Ophthalmology 2021; 21: 153 (IGR: 22-1)

92438 What Is New in Glaucoma: From Treatment to Biological Perspectives
Marolo P
Journal of Ophthalmology 2021; 2021: 5013529 (IGR: 22-1)

92172 The Aging Lens and Glaucoma in persons over 50: Why early cataract surgery/refractive lensectomy and microinvasive trabecular bypass can prevent blindness and cure elevated eye pressure
Capellan P
Journal of the National Medical Association 2021; 113: 471-473 (IGR: 22-1)

92362 What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews
Michelessi M
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)

92154 Risk factors leading to trabeculectomy surgery of glaucoma patient using Japanese nationwide administrative claims data: a retrospective non-interventional cohort study
Tarasawa K
BMC Ophthalmology 2021; 21: 153 (IGR: 22-1)

92418 Changing trends in glaucoma surgery within Australia
Huang S
British Journal of Ophthalmology 2022; 106: 957-961 (IGR: 22-1)

92438 What Is New in Glaucoma: From Treatment to Biological Perspectives
Nuzzi A
Journal of Ophthalmology 2021; 2021: 5013529 (IGR: 22-1)

92540 Surgical and Perioperative Considerations for the Treatment of Cataract in Eyes with Glaucoma: A Literature Review
Georgoudis P
Journal of Ophthalmology 2021; 2021: 5575445 (IGR: 22-1)

92586 The Effects of Glaucoma and Glaucoma Therapies on Corneal Endothelial Cell Density
Radcliffe NM
Journal of Glaucoma 2021; 30: 209-218 (IGR: 22-1)

92418 Changing trends in glaucoma surgery within Australia
Cameron C
British Journal of Ophthalmology 2022; 106: 957-961 (IGR: 22-1)

92540 Surgical and Perioperative Considerations for the Treatment of Cataract in Eyes with Glaucoma: A Literature Review
Gatzioufas Z
Journal of Ophthalmology 2021; 2021: 5575445 (IGR: 22-1)

92362 What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews
Virgili G
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)

92586 The Effects of Glaucoma and Glaucoma Therapies on Corneal Endothelial Cell Density
Garg S
Journal of Glaucoma 2021; 30: 209-218 (IGR: 22-1)

92154 Risk factors leading to trabeculectomy surgery of glaucoma patient using Japanese nationwide administrative claims data: a retrospective non-interventional cohort study
Fushimi K
BMC Ophthalmology 2021; 21: 153 (IGR: 22-1)

92540 Surgical and Perioperative Considerations for the Treatment of Cataract in Eyes with Glaucoma: A Literature Review
Vergados A
Journal of Ophthalmology 2021; 2021: 5575445 (IGR: 22-1)

92586 The Effects of Glaucoma and Glaucoma Therapies on Corneal Endothelial Cell Density
Wiley WF
Journal of Glaucoma 2021; 30: 209-218 (IGR: 22-1)

92362 What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews
Barbosa Breda J
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)

92154 Risk factors leading to trabeculectomy surgery of glaucoma patient using Japanese nationwide administrative claims data: a retrospective non-interventional cohort study
Fujimori K
BMC Ophthalmology 2021; 21: 153 (IGR: 22-1)

92418 Changing trends in glaucoma surgery within Australia
Selva D
British Journal of Ophthalmology 2022; 106: 957-961 (IGR: 22-1)

92586 The Effects of Glaucoma and Glaucoma Therapies on Corneal Endothelial Cell Density
Yeu E
Journal of Glaucoma 2021; 30: 209-218 (IGR: 22-1)

92418 Changing trends in glaucoma surgery within Australia
Casson RJ
British Journal of Ophthalmology 2022; 106: 957-961 (IGR: 22-1)

92154 Risk factors leading to trabeculectomy surgery of glaucoma patient using Japanese nationwide administrative claims data: a retrospective non-interventional cohort study
Nakazawa T
BMC Ophthalmology 2021; 21: 153 (IGR: 22-1)

92362 What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews
Cutolo CA; Pazos M
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)

92418 Changing trends in glaucoma surgery within Australia
Wong CX
British Journal of Ophthalmology 2022; 106: 957-961 (IGR: 22-1)

92586 The Effects of Glaucoma and Glaucoma Therapies on Corneal Endothelial Cell Density
Berdahl JP
Journal of Glaucoma 2021; 30: 209-218 (IGR: 22-1)

92362 What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews
Katsanos A
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)

92586 The Effects of Glaucoma and Glaucoma Therapies on Corneal Endothelial Cell Density
Kahook MY
Journal of Glaucoma 2021; 30: 209-218 (IGR: 22-1)

92362 What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews
Garhöfer G; Kolko M; Prokosch-Willing V; Al Rajhi AA; Lum F; Musch D; Gedde S; Li T
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)

90998 Achieving low target intraocular pressures in severe glaucoma
Warjri GB
European Journal of Ophthalmology 2020; 0: 1120672120979903 (IGR: 21-4)

91024 Clinical profile and outcome of early surgery in neonatal-onset glaucoma presenting over a 5-year period
Kaushik S
British Journal of Ophthalmology 2022; 106: 368-375 (IGR: 21-4)

91337 Changes in Performance of Glaucoma Surgeries 1994 through 2017 Based on Claims and Payment Data for United States Medicare Beneficiaries
Boland MV
Ophthalmology. Glaucoma 2021; 4: 463-471 (IGR: 21-4)

91024 Clinical profile and outcome of early surgery in neonatal-onset glaucoma presenting over a 5-year period
Dhingra D
British Journal of Ophthalmology 2022; 106: 368-375 (IGR: 21-4)

91337 Changes in Performance of Glaucoma Surgeries 1994 through 2017 Based on Claims and Payment Data for United States Medicare Beneficiaries
Corcoran KJ
Ophthalmology. Glaucoma 2021; 4: 463-471 (IGR: 21-4)